-
1
-
-
84898775157
-
Pharmacological treatment of Parkinson disease: A review
-
24756517
-
Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311:1670-83.
-
(2014)
JAMA
, vol.311
, pp. 1670-1683
-
-
Connolly, B.S.1
Lang, A.E.2
-
2
-
-
84890858709
-
Drug discovery in Parkinson's disease-Update and developments in the use of cellular models
-
3596173 23505333
-
Skibinski G, Finkbeiner S. Drug discovery in Parkinson's disease-Update and developments in the use of cellular models. Int J High Throughput Screen. 2011;2011:15-25.
-
(2011)
Int J High Throughput Screen
, vol.2011
, pp. 15-25
-
-
Skibinski, G.1
Finkbeiner, S.2
-
3
-
-
37349004102
-
Parkinson's disease
-
Spec No. 2:R183-194
-
Thomas B, Beal MF. Parkinson's disease. Hum Mol Genet. 2007; 16 Spec No. 2:R183-194.
-
(2007)
Hum Mol Genet
, vol.16
-
-
Thomas, B.1
Beal, M.F.2
-
4
-
-
68949197599
-
Parkinson's disease: From molecular pathways in disease to therapeutic approaches
-
2819797 1:CAS:528:DC%2BD1MXpvFaqsro%3D 19624258
-
Thomas B. Parkinson's disease: from molecular pathways in disease to therapeutic approaches. Antioxid Redox Signal. 2009;11:2077-82.
-
(2009)
Antioxid Redox Signal
, vol.11
, pp. 2077-2082
-
-
Thomas, B.1
-
5
-
-
84906306620
-
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: Future therapeutic perspectives
-
24954676
-
Schapira AH, Olanow CW, Greenamyre JT, Bezard E. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Lancet. 2014;384:545-55.
-
(2014)
Lancet
, vol.384
, pp. 545-555
-
-
Schapira, A.H.1
Olanow, C.W.2
Greenamyre, J.T.3
Bezard, E.4
-
6
-
-
44949138796
-
A review of Parkinson's disease
-
18398010
-
Davie CA. A review of Parkinson's disease. Br Med Bull. 2008;86:109-27.
-
(2008)
Br Med Bull
, vol.86
, pp. 109-127
-
-
Davie, C.A.1
-
7
-
-
84873490552
-
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease
-
23370739
-
Utsumi H, Okuma Y, Kano O, Suzuki Y, Iijima M, Tomimitsu H, et al. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease. Intern Med. 2013;52:325-32.
-
(2013)
Intern Med
, vol.52
, pp. 325-332
-
-
Utsumi, H.1
Okuma, Y.2
Kano, O.3
Suzuki, Y.4
Iijima, M.5
Tomimitsu, H.6
-
8
-
-
79960317325
-
Prospects for cannabinoid therapies in basal ganglia disorders
-
3165947 1:CAS:528:DC%2BC3MXps1Sjtbw%3D 21545415
-
Fernandez-Ruiz J, Moreno-Martet M, Rodriguez-Cueto C, Palomo-Garo C, Gomez-Canas M, Valdeolivas S, et al. Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol. 2011;163:1365-78.
-
(2011)
Br J Pharmacol
, vol.163
, pp. 1365-1378
-
-
Fernandez-Ruiz, J.1
Moreno-Martet, M.2
Rodriguez-Cueto, C.3
Palomo-Garo, C.4
Gomez-Canas, M.5
Valdeolivas, S.6
-
9
-
-
33846795915
-
Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus
-
17267577
-
Hashimotodani Y, Ohno-Shosaku T, Kano M. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci. 2007;27:1211-9.
-
(2007)
J Neurosci
, vol.27
, pp. 1211-1219
-
-
Hashimotodani, Y.1
Ohno-Shosaku, T.2
Kano, M.3
-
10
-
-
84864002386
-
Differential distribution of diacylglycerol lipase-alpha and N-acylphosphatidylethanolamine-specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats
-
3703832 22573306
-
Hegyi Z, Hollo K, Kis G, Mackie K, Antal M. Differential distribution of diacylglycerol lipase-alpha and N-acylphosphatidylethanolamine-specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats. Glia. 2012;60:1316-29.
-
(2012)
Glia
, vol.60
, pp. 1316-1329
-
-
Hegyi, Z.1
Hollo, K.2
Kis, G.3
Mackie, K.4
Antal, M.5
-
11
-
-
84935104912
-
A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells
-
25519724
-
Ivanov I, Borchert P, Hinz B. A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells. Anal Bioanal Chem. 2014;407:1781-7.
-
(2014)
Anal Bioanal Chem
, vol.407
, pp. 1781-1787
-
-
Ivanov, I.1
Borchert, P.2
Hinz, B.3
-
12
-
-
77949349615
-
Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: Physiological and pharmacological implications
-
2835397 1:CAS:528:DC%2BC3cXhsVSltbnK 20133390
-
Snider NT, Walker VJ, Hollenberg PF. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Pharmacol Rev. 2010;62:136-54.
-
(2010)
Pharmacol Rev
, vol.62
, pp. 136-154
-
-
Snider, N.T.1
Walker, V.J.2
Hollenberg, P.F.3
-
13
-
-
78650120798
-
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB(1) and CB(2)
-
2993256 1:CAS:528:DC%2BC3MXktler 21079038
-
Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol Rev. 2010;62:588-631.
-
(2010)
Pharmacol Rev
, vol.62
, pp. 588-631
-
-
Pertwee, R.G.1
Howlett, A.C.2
Abood, M.E.3
Alexander, S.P.4
Di Marzo, V.5
Elphick, M.R.6
-
14
-
-
77952666794
-
Quantification of brain endocannabinoid levels: Methods, interpretations and pitfalls
-
2931546 1:CAS:528:DC%2BC3cXpslyrur4%3D 20590555
-
Buczynski MW, Parsons LH. Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. Br J Pharmacol. 2010;160:423-42.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 423-442
-
-
Buczynski, M.W.1
Parsons, L.H.2
-
15
-
-
0030590440
-
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
-
8814296
-
Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 1996;393:231-5.
-
(1996)
FEBS Lett
, vol.393
, pp. 231-235
-
-
Felder, C.C.1
Nielsen, A.2
Briley, E.M.3
Palkovits, M.4
Priller, J.5
Axelrod, J.6
-
16
-
-
0033574179
-
Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
-
10079192
-
Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, et al. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun. 1999;256:377-80.
-
(1999)
Biochem Biophys Res Commun
, vol.256
, pp. 377-380
-
-
Bisogno, T.1
Berrendero, F.2
Ambrosino, G.3
Cebeira, M.4
Ramos, J.A.5
Fernandez-Ruiz, J.J.6
-
17
-
-
0029012014
-
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
-
7605349
-
Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995;50:83-90.
-
(1995)
Biochem Pharmacol
, vol.50
, pp. 83-90
-
-
Mechoulam, R.1
Ben-Shabat, S.2
Hanus, L.3
Ligumsky, M.4
Kaminski, N.E.5
Schatz, A.R.6
-
18
-
-
0034058250
-
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide
-
10779390
-
Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol. 2000;57:1045-50.
-
(2000)
Mol Pharmacol
, vol.57
, pp. 1045-1050
-
-
Gonsiorek, W.1
Lunn, C.2
Fan, X.3
Narula, S.4
Lundell, D.5
Hipkin, R.W.6
-
19
-
-
0034614374
-
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
-
10617657
-
Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, et al. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem. 2000;275:605-12.
-
(2000)
J Biol Chem
, vol.275
, pp. 605-612
-
-
Sugiura, T.1
Kondo, S.2
Kishimoto, S.3
Miyashita, T.4
Nakane, S.5
Kodaka, T.6
-
20
-
-
0025954862
-
Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
-
1992016
-
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991;11:563-83.
-
(1991)
J Neurosci
, vol.11
, pp. 563-583
-
-
Herkenham, M.1
Lynn, A.B.2
Johnson, M.R.3
Melvin, L.S.4
De Costa, B.R.5
Rice, K.C.6
-
21
-
-
0033936028
-
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
-
Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J. 2000;14:1432-8.
-
(2000)
FASEB J
, vol.14
, pp. 1432-1438
-
-
Di Marzo, V.1
Hill, M.P.2
Bisogno, T.3
Crossman, A.R.4
Brotchie, J.M.5
-
22
-
-
0034107992
-
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats
-
Di Marzo V, Berrendero F, Bisogno T, Gonzalez S, Cavaliere P, Romero J, et al. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. J Neurochem. 2000;74:1627-35.
-
(2000)
J Neurochem
, vol.74
, pp. 1627-1635
-
-
Di Marzo, V.1
Berrendero, F.2
Bisogno, T.3
Gonzalez, S.4
Cavaliere, P.5
Romero, J.6
-
23
-
-
0033362973
-
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
-
10204543
-
Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci. 1999;2:358-63.
-
(1999)
Nat Neurosci
, vol.2
, pp. 358-363
-
-
Giuffrida, A.1
Parsons, L.H.2
Kerr, T.M.3
Rodriguez De Fonseca, F.4
Navarro, M.5
Piomelli, D.6
-
24
-
-
84875086499
-
Endocannabinoid system: Potential novel targets for treatment of schizophrenia
-
3594631 1:CAS:528:DC%2BC3sXjsFyis74%3D 23220619
-
Saito A, Ballinger MD, Pletnikov MV, Wong DF, Kamiya A. Endocannabinoid system: potential novel targets for treatment of schizophrenia. Neurobiol Dis. 2013;53:10-7.
-
(2013)
Neurobiol Dis
, vol.53
, pp. 10-17
-
-
Saito, A.1
Ballinger, M.D.2
Pletnikov, M.V.3
Wong, D.F.4
Kamiya, A.5
-
25
-
-
33846465449
-
The emerging functions of endocannabinoid signaling during CNS development
-
17222464
-
Harkany T, Guzman M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci. 2007;28:83-92.
-
(2007)
Trends Pharmacol Sci
, vol.28
, pp. 83-92
-
-
Harkany, T.1
Guzman, M.2
Galve-Roperh, I.3
Berghuis, P.4
Devi, L.A.5
Mackie, K.6
-
26
-
-
10744229235
-
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
-
2173631 1:CAS:528:DC%2BD3sXovFCnur8%3D 14610053
-
Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol. 2003;163:463-8.
-
(2003)
J Cell Biol
, vol.163
, pp. 463-468
-
-
Bisogno, T.1
Howell, F.2
Williams, G.3
Minassi, A.4
Cascio, M.G.5
Ligresti, A.6
-
27
-
-
84895765600
-
Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS
-
3954479 1:CAS:528:DC%2BC2cXjsVensbk%3D 24102242
-
Murataeva N, Straiker A, Mackie K. Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. Br J Pharmacol. 2014;171:1379-91.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 1379-1391
-
-
Murataeva, N.1
Straiker, A.2
Mackie, K.3
-
28
-
-
0028589390
-
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
-
7990962
-
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994;372:686-91.
-
(1994)
Nature
, vol.372
, pp. 686-691
-
-
Di Marzo, V.1
Fontana, A.2
Cadas, H.3
Schinelli, S.4
Cimino, G.5
Schwartz, J.C.6
-
29
-
-
0033610794
-
Anandamide hydrolysis by human cells in culture and brain
-
9822713
-
Maccarrone M, van der Stelt M, Rossi A, Veldink GA, Vliegenthart JF, Agro AF. Anandamide hydrolysis by human cells in culture and brain. J Biol Chem. 1998;273:32332-9.
-
(1998)
J Biol Chem
, vol.273
, pp. 32332-32339
-
-
Maccarrone, M.1
Van Der Stelt, M.2
Rossi, A.3
Veldink, G.A.4
Vliegenthart, J.F.5
Agro, A.F.6
-
30
-
-
84867113185
-
Endocannabinoid signaling and synaptic function
-
3517813 1:CAS:528:DC%2BC38XhsVKgsLvF 23040807
-
Castillo PE, Younts TJ, Chavez AE, Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron. 2012;76:70-81.
-
(2012)
Neuron
, vol.76
, pp. 70-81
-
-
Castillo, P.E.1
Younts, T.J.2
Chavez, A.E.3
Hashimotodani, Y.4
-
31
-
-
0032494704
-
A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain
-
1:CAS:528:DyaK1cXns1ersL0%3D 9842734
-
Egertova M, Giang DK, Cravatt BF, Elphick MR. A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci. 1998;265:2081-5.
-
(1998)
Proc Biol Sci
, vol.265
, pp. 2081-2085
-
-
Egertova, M.1
Giang, D.K.2
Cravatt, B.F.3
Elphick, M.R.4
-
32
-
-
3242751838
-
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala
-
15233753
-
Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004;20:441-58.
-
(2004)
Eur J Neurosci
, vol.20
, pp. 441-458
-
-
Gulyas, A.I.1
Cravatt, B.F.2
Bracey, M.H.3
Dinh, T.P.4
Piomelli, D.5
Boscia, F.6
-
33
-
-
72149110067
-
Endocannabinoid-Metabolising Enzymes
-
Alexander S. Endocannabinoid-Metabolising Enzymes. Br J Pharmacol. 2009;158:S220-1.
-
(2009)
Br J Pharmacol
, vol.158
, pp. 220-221
-
-
Alexander, S.1
-
34
-
-
0032055496
-
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: Connections with anandamide
-
1219315 9512456
-
Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem J. 1998;331(Pt 1):15-9.
-
(1998)
Biochem J
, vol.331
, Issue.PART 1
, pp. 15-19
-
-
Di Marzo, V.1
Bisogno, T.2
Sugiura, T.3
Melck, D.4
De Petrocellis, L.5
-
35
-
-
0032559369
-
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand
-
9475172
-
Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 1998;422:69-73.
-
(1998)
FEBS Lett
, vol.422
, pp. 69-73
-
-
Goparaju, S.K.1
Ueda, N.2
Yamaguchi, H.3
Yamamoto, S.4
-
36
-
-
0036678094
-
Brain monoglyceride lipase participating in endocannabinoid inactivation
-
125056 1:CAS:528:DC%2BD38Xmt1ChtLs%3D 12136125
-
Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A. 2002;99:10819-24.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 10819-10824
-
-
Dinh, T.P.1
Carpenter, D.2
Leslie, F.M.3
Freund, T.F.4
Katona, I.5
Sensi, S.L.6
-
37
-
-
84864353441
-
Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression
-
3409771 1:CAS:528:DC%2BC38Xht1Gkt77I 22783023
-
Tanimura A, Uchigashima M, Yamazaki M, Uesaka N, Mikuni T, Abe M, et al. Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. Proc Natl Acad Sci U S A. 2012;109:12195-200.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 12195-12200
-
-
Tanimura, A.1
Uchigashima, M.2
Yamazaki, M.3
Uesaka, N.4
Mikuni, T.5
Abe, M.6
-
38
-
-
22344439403
-
A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells
-
2171605 1:CAS:528:DC%2BD2MXltVanurg%3D 15939762
-
Bektas M, Payne SG, Liu H, Goparaju S, Milstien S, Spiegel S. A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells. J Cell Biol. 2005;169:801-11.
-
(2005)
J Cell Biol
, vol.169
, pp. 801-811
-
-
Bektas, M.1
Payne, S.G.2
Liu, H.3
Goparaju, S.4
Milstien, S.5
Spiegel, S.6
-
40
-
-
30444450122
-
-
Plenum Publishers Georgetown, Texas, USA
-
Marzo VD. Cannabinoids. Georgetown, Texas, USA: Plenum Publishers; 2004.
-
(2004)
Cannabinoids
-
-
Marzo, V.D.1
-
41
-
-
38449120611
-
Cannabinoids and neuroprotection in basal ganglia disorders
-
17952653
-
Sagredo O, Garcia-Arencibia M, de Lago E, Finetti S, Decio A, Fernandez-Ruiz J. Cannabinoids and neuroprotection in basal ganglia disorders. Mol Neurobiol. 2007;36:82-91.
-
(2007)
Mol Neurobiol
, vol.36
, pp. 82-91
-
-
Sagredo, O.1
Garcia-Arencibia, M.2
De Lago, E.3
Finetti, S.4
Decio, A.5
Fernandez-Ruiz, J.6
-
42
-
-
66449132820
-
WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
-
2755595 19490092
-
Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E, et al. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur J Neurosci. 2009;29:2177-86.
-
(2009)
Eur J Neurosci
, vol.29
, pp. 2177-2186
-
-
Price, D.A.1
Martinez, A.A.2
Seillier, A.3
Koek, W.4
Acosta, Y.5
Fernandez, E.6
-
43
-
-
1542675293
-
The basal ganglia and motor control
-
2565420 14640312
-
Groenewegen HJ. The basal ganglia and motor control. Neural Plast. 2003;10:107-20.
-
(2003)
Neural Plast
, vol.10
, pp. 107-120
-
-
Groenewegen, H.J.1
-
44
-
-
84872256489
-
Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
-
3579248 1:CAS:528:DC%2BC3sXns1KhsA%3D%3D 22625422
-
Fernandez-Ruiz J, Sagredo O, Pazos MR, Garcia C, Pertwee R, Mechoulam R, et al. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? Br J Clin Pharmacol. 2013;75:323-33.
-
(2013)
Br J Clin Pharmacol
, vol.75
, pp. 323-333
-
-
Fernandez-Ruiz, J.1
Sagredo, O.2
Pazos, M.R.3
Garcia, C.4
Pertwee, R.5
Mechoulam, R.6
-
45
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
-
2165569
-
Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561-4.
-
(1990)
Nature
, vol.346
, pp. 561-564
-
-
Matsuda, L.A.1
Lolait, S.J.2
Brownstein, M.J.3
Young, A.C.4
Bonner, T.I.5
-
46
-
-
0027515373
-
Molecular characterization of a peripheral receptor for cannabinoids
-
7689702
-
Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61-5.
-
(1993)
Nature
, vol.365
, pp. 61-65
-
-
Munro, S.1
Thomas, K.L.2
Abu-Shaar, M.3
-
47
-
-
18444376760
-
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
-
12037135
-
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161-202.
-
(2002)
Pharmacol Rev
, vol.54
, pp. 161-202
-
-
Howlett, A.C.1
Barth, F.2
Bonner, T.I.3
Cabral, G.4
Casellas, P.5
Devane, W.A.6
-
48
-
-
0028823316
-
Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor
-
7472417
-
Mackie K, Lai Y, Westenbroek R, Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci. 1995;15:6552-61.
-
(1995)
J Neurosci
, vol.15
, pp. 6552-6561
-
-
Mackie, K.1
Lai, Y.2
Westenbroek, R.3
Mitchell, R.4
-
49
-
-
0030746408
-
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
-
9242259
-
Twitchell W, Brown S, Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol. 1997;78:43-50.
-
(1997)
J Neurophysiol
, vol.78
, pp. 43-50
-
-
Twitchell, W.1
Brown, S.2
Mackie, K.3
-
50
-
-
75749126604
-
Signal transduction of the CB1 cannabinoid receptor
-
19620237
-
Turu G, Hunyady L. Signal transduction of the CB1 cannabinoid receptor. J Mol Endocrinol. 2010;44:75-85.
-
(2010)
J Mol Endocrinol
, vol.44
, pp. 75-85
-
-
Turu, G.1
Hunyady, L.2
-
51
-
-
0029842102
-
Regulation of a neuronal form of focal adhesion kinase by anandamide
-
8781236
-
Derkinderen P, Toutant M, Burgaya F, Le Bert M, Siciliano JC, de Franciscis V, et al. Regulation of a neuronal form of focal adhesion kinase by anandamide. Science. 1996;273:1719-22.
-
(1996)
Science
, vol.273
, pp. 1719-1722
-
-
Derkinderen, P.1
Toutant, M.2
Burgaya, F.3
Le Bert, M.4
Siciliano, J.C.5
De Franciscis, V.6
-
52
-
-
0037184060
-
Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway
-
12133838
-
Gomez Del Pulgar T, De Ceballos ML, Guzman M, Velasco G. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem. 2002;277:36527-33.
-
(2002)
J Biol Chem
, vol.277
, pp. 36527-36533
-
-
Gomez Del Pulgar, T.1
De Ceballos, M.L.2
Guzman, M.3
Velasco, G.4
-
53
-
-
0031724645
-
Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes
-
9804618
-
Sanchez C, Galve-Roperh I, Rueda D, Guzman M. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol. 1998;54:834-43.
-
(1998)
Mol Pharmacol
, vol.54
, pp. 834-843
-
-
Sanchez, C.1
Galve-Roperh, I.2
Rueda, D.3
Guzman, M.4
-
54
-
-
0032982520
-
The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells
-
10027878
-
Waksman Y, Olson JM, Carlisle SJ, Cabral GA. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther. 1999;288:1357-66.
-
(1999)
J Pharmacol Exp Ther
, vol.288
, pp. 1357-1366
-
-
Waksman, Y.1
Olson, J.M.2
Carlisle, S.J.3
Cabral, G.A.4
-
55
-
-
77952283131
-
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
-
20206137
-
Bosier B, Muccioli GG, Hermans E, Lambert DM. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem Pharmacol. 2010;80:1-12.
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 1-12
-
-
Bosier, B.1
Muccioli, G.G.2
Hermans, E.3
Lambert, D.M.4
-
56
-
-
84859208807
-
Mitochondrial CB(1) receptors regulate neuronal energy metabolism
-
22388959
-
Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E, et al. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci. 2012;15:558-64.
-
(2012)
Nat Neurosci
, vol.15
, pp. 558-564
-
-
Benard, G.1
Massa, F.2
Puente, N.3
Lourenco, J.4
Bellocchio, L.5
Soria-Gomez, E.6
-
57
-
-
0036669281
-
The endogenous cannabinoid system and the basal ganglia. Biochemical, pharmacological, and therapeutic aspects
-
12182961
-
Romero J, Lastres-Becker I, de Miguel R, Berrendero F, Ramos JA, Fernandez-Ruiz J. The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. Pharmacol Ther. 2002;95:137-52.
-
(2002)
Pharmacol Ther
, vol.95
, pp. 137-152
-
-
Romero, J.1
Lastres-Becker, I.2
De Miguel, R.3
Berrendero, F.4
Ramos, J.A.5
Fernandez-Ruiz, J.6
-
58
-
-
43649097012
-
Expression and function of CB1 receptor in the rat striatum: Localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors
-
17957223
-
Martin AB, Fernandez-Espejo E, Ferrer B, Gorriti MA, Bilbao A, Navarro M, et al. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology. 2008;33:1667-79.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 1667-1679
-
-
Martin, A.B.1
Fernandez-Espejo, E.2
Ferrer, B.3
Gorriti, M.A.4
Bilbao, A.5
Navarro, M.6
-
59
-
-
84904961722
-
Direct and indirect pathways of basal ganglia: A critical reappraisal
-
25065439
-
Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat Neurosci. 2014;17:1022-30.
-
(2014)
Nat Neurosci
, vol.17
, pp. 1022-1030
-
-
Calabresi, P.1
Picconi, B.2
Tozzi, A.3
Ghiglieri, V.4
Di Filippo, M.5
-
60
-
-
84921344514
-
Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry
-
25522178
-
Munoz-Arenas G, Paz-Bermudez F, Baez-Cordero A, Caballero-Floran R, Gonzalez-Hernandez B, Floran B, et al. Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry. Synapse. 2014;69:103-14.
-
(2014)
Synapse
, vol.69
, pp. 103-114
-
-
Munoz-Arenas, G.1
Paz-Bermudez, F.2
Baez-Cordero, A.3
Caballero-Floran, R.4
Gonzalez-Hernandez, B.5
Floran, B.6
-
61
-
-
84940612728
-
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: Changes following experimental parkinsonism
-
Epub ahead of print
-
Sierra S, Luquin N, Rico AJ, Gomez-Bautista V, Roda E, Dopeso-Reyes IG et al. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. Brain Struct Funct. 2014. Epub ahead of print.
-
(2014)
Brain Struct Funct
-
-
Sierra, S.1
Luquin, N.2
Rico, A.J.3
Gomez-Bautista, V.4
Roda, E.5
Dopeso-Reyes, I.G.6
-
62
-
-
0026560323
-
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
-
1376455
-
Mailleux P, Vanderhaeghen JJ. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 1992;48:655-68.
-
(1992)
Neuroscience
, vol.48
, pp. 655-668
-
-
Mailleux, P.1
Vanderhaeghen, J.J.2
-
63
-
-
0025802871
-
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
-
1909204
-
Herkenham M, Lynn AB, de Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 1991;547:267-74.
-
(1991)
Brain Res
, vol.547
, pp. 267-274
-
-
Herkenham, M.1
Lynn, A.B.2
De Costa, B.R.3
Richfield, E.K.4
-
64
-
-
84885107433
-
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats
-
3792868 1:CAS:528:DC%2BC3sXhs1aks7vE 24116178
-
Chaves-Kirsten GP, Mazucanti CH, Real CC, Souza BM, Britto LR, Torrao AS. Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats. PLoS One. 2013;8:e76874.
-
(2013)
PLoS One
, vol.8
, pp. 76874
-
-
Chaves-Kirsten, G.P.1
Mazucanti, C.H.2
Real, C.C.3
Souza, B.M.4
Britto, L.R.5
Torrao, A.S.6
-
65
-
-
15244356828
-
Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: A combined immunochemical and pharmacological analysis
-
15772347
-
Kofalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, et al. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J Neurosci. 2005;25:2874-84.
-
(2005)
J Neurosci
, vol.25
, pp. 2874-2884
-
-
Kofalvi, A.1
Rodrigues, R.J.2
Ledent, C.3
Mackie, K.4
Vizi, E.S.5
Cunha, R.A.6
-
66
-
-
0034129730
-
Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: A double-label in situ hybridization study
-
10842353
-
Hohmann AG, Herkenham M. Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse. 2000;37:71-80.
-
(2000)
Synapse
, vol.37
, pp. 71-80
-
-
Hohmann, A.G.1
Herkenham, M.2
-
67
-
-
77953044816
-
Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex
-
2905527 1:CAS:528:DC%2BC3cXovVOis7Y%3D 20505090
-
Chiu CQ, Puente N, Grandes P, Castillo PE. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J Neurosci. 2010;30:7236-48.
-
(2010)
J Neurosci
, vol.30
, pp. 7236-7248
-
-
Chiu, C.Q.1
Puente, N.2
Grandes, P.3
Castillo, P.E.4
-
68
-
-
84896943343
-
Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats
-
24607771
-
Coria SM, Roura-Martinez D, Ucha M, Assis MA, Miguens M, Garcia-Lecumberri C, et al. Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats. Prog Neuropsychopharmacol Biol Psychiatry. 2014;53:15-22.
-
(2014)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.53
, pp. 15-22
-
-
Coria, S.M.1
Roura-Martinez, D.2
Ucha, M.3
Assis, M.A.4
Miguens, M.5
Garcia-Lecumberri, C.6
-
69
-
-
84865982317
-
CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation
-
3298893 22416230
-
Van Waes V, Beverley JA, Siman H, Tseng KY, Steiner H. CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation. Front Pharmacol. 2012;3:21.
-
(2012)
Front Pharmacol
, vol.3
, pp. 21
-
-
Van Waes, V.1
Beverley, J.A.2
Siman, H.3
Tseng, K.Y.4
Steiner, H.5
-
70
-
-
58149096475
-
Looking for the role of cannabinoid receptor heteromers in striatal function
-
2635338 1:CAS:528:DC%2BD1MXhsVKiug%3D%3D 18691604
-
Ferre S, Goldberg SR, Lluis C, Franco R. Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology. 2009;56 Suppl 1:226-34.
-
(2009)
Neuropharmacology
, vol.56
, pp. 226-234
-
-
Ferre, S.1
Goldberg, S.R.2
Lluis, C.3
Franco, R.4
-
71
-
-
79960676744
-
Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response
-
3179266 1:CAS:528:DC%2BC3MXps1Smsbo%3D 21775596
-
Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, et al. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci. 2011;31:10506-15.
-
(2011)
J Neurosci
, vol.31
, pp. 10506-10515
-
-
Hill, M.N.1
McLaughlin, R.J.2
Pan, B.3
Fitzgerald, M.L.4
Roberts, C.J.5
Lee, T.T.6
-
72
-
-
67349155593
-
Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease
-
19481011
-
Allen KL, Waldvogel HJ, Glass M, Faull RL. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease. J Chem Neuroanat. 2009;37:266-81.
-
(2009)
J Chem Neuroanat
, vol.37
, pp. 266-281
-
-
Allen, K.L.1
Waldvogel, H.J.2
Glass, M.3
Faull, R.L.4
-
73
-
-
68349152770
-
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease
-
19524019
-
Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, et al. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. Neuroscience. 2009;163:456-65.
-
(2009)
Neuroscience
, vol.163
, pp. 456-465
-
-
Dowie, M.J.1
Bradshaw, H.B.2
Howard, M.L.3
Nicholson, L.F.4
Faull, R.L.5
Hannan, A.J.6
-
74
-
-
76749165654
-
Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat
-
3659808 1:CAS:528:DC%2BC3cXit1Kisrc%3D 20097273
-
Walsh S, Mnich K, Mackie K, Gorman AM, Finn DP, Dowd E. Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat. Brain Res Bull. 2010;81:543-8.
-
(2010)
Brain Res Bull
, vol.81
, pp. 543-548
-
-
Walsh, S.1
Mnich, K.2
Mackie, K.3
Gorman, A.M.4
Finn, D.P.5
Dowd, E.6
-
75
-
-
77953216492
-
Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence
-
20477755
-
Spiga S, Lintas A, Migliore M, Diana M. Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence. Addict Biol. 2010;15:266-76.
-
(2010)
Addict Biol
, vol.15
, pp. 266-276
-
-
Spiga, S.1
Lintas, A.2
Migliore, M.3
Diana, M.4
-
76
-
-
37349043211
-
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area
-
2238033 1:CAS:528:DC%2BD1cXhtlClsA%3D%3D 17655884
-
Matyas F, Urban GM, Watanabe M, Mackie K, Zimmer A, Freund TF, et al. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology. 2008;54:95-107.
-
(2008)
Neuropharmacology
, vol.54
, pp. 95-107
-
-
Matyas, F.1
Urban, G.M.2
Watanabe, M.3
Mackie, K.4
Zimmer, A.5
Freund, T.F.6
-
77
-
-
84896729005
-
Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus
-
24508153
-
Dasilva M, Grieve KL, Cudeiro J, Rivadulla C. Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus. Neuroscience. 2014;265:72-82.
-
(2014)
Neuroscience
, vol.265
, pp. 72-82
-
-
Dasilva, M.1
Grieve, K.L.2
Cudeiro, J.3
Rivadulla, C.4
-
78
-
-
0033555839
-
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
-
9888857
-
Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999;283:401-4.
-
(1999)
Science
, vol.283
, pp. 401-404
-
-
Ledent, C.1
Valverde, O.2
Cossu, G.3
Petitet, F.4
Aubert, J.F.5
Beslot, F.6
-
79
-
-
0033545866
-
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
-
21937 1:CAS:528:DyaK1MXjtFCnuro%3D 10318961
-
Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A. 1999;96:5780-5.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 5780-5785
-
-
Zimmer, A.1
Zimmer, A.M.2
Hohmann, A.G.3
Herkenham, M.4
Bonner, T.I.5
-
80
-
-
84875941411
-
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently
-
22391102
-
Polissidis A, Galanopoulos A, Naxakis G, Papahatjis D, Papadopoulou-Daifoti Z, Antoniou K. The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. Int J Neuropsychopharmacol. 2013;16:393-403.
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, pp. 393-403
-
-
Polissidis, A.1
Galanopoulos, A.2
Naxakis, G.3
Papahatjis, D.4
Papadopoulou-Daifoti, Z.5
Antoniou, K.6
-
81
-
-
20444381263
-
Functional neuroanatomy of the endocannabinoid system
-
15936805
-
Pazos MR, Nunez E, Benito C, Tolon RM, Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacol Biochem Behav. 2005;81:239-47.
-
(2005)
Pharmacol Biochem Behav
, vol.81
, pp. 239-247
-
-
Pazos, M.R.1
Nunez, E.2
Benito, C.3
Tolon, R.M.4
Romero, J.5
-
82
-
-
77954406421
-
Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
-
2919281 20468046
-
Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia. 2010;58:1017-30.
-
(2010)
Glia
, vol.58
, pp. 1017-1030
-
-
Stella, N.1
-
83
-
-
84921020535
-
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors
-
25452006
-
Metna-Laurent M, Marsicano G. Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors. Glia. 2014;63:353-64.
-
(2014)
Glia
, vol.63
, pp. 353-364
-
-
Metna-Laurent, M.1
Marsicano, G.2
-
84
-
-
0035112869
-
Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus
-
11157068
-
Rodriguez JJ, Mackie K, Pickel VM. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J Neurosci. 2001;21:823-33.
-
(2001)
J Neurosci
, vol.21
, pp. 823-833
-
-
Rodriguez, J.J.1
Mackie, K.2
Pickel, V.M.3
-
85
-
-
0345621691
-
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons
-
10341254
-
Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci. 1999;19:4544-58.
-
(1999)
J Neurosci
, vol.19
, pp. 4544-4558
-
-
Katona, I.1
Sperlagh, B.2
Sik, A.3
Kafalvi, A.4
Vizi, E.S.5
Mackie, K.6
-
86
-
-
0031929438
-
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
-
9460749
-
Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 1998;83:393-411.
-
(1998)
Neuroscience
, vol.83
, pp. 393-411
-
-
Tsou, K.1
Brown, S.2
Sanudo-Pena, M.C.3
Mackie, K.4
Walker, J.M.5
-
87
-
-
0142166330
-
Cannabinoids: Potential anticancer agents
-
14570037
-
Guzman M. Cannabinoids: potential anticancer agents. Nat Rev Cancer. 2003;3:745-55.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 745-755
-
-
Guzman, M.1
-
88
-
-
40849100074
-
Endocannabinoids mediate neuron-astrocyte communication
-
18367089
-
Navarrete M, Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron. 2008;57:883-93.
-
(2008)
Neuron
, vol.57
, pp. 883-893
-
-
Navarrete, M.1
Araque, A.2
-
89
-
-
1842428537
-
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
-
15044630
-
Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, et al. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol. 2004;65:999-1007.
-
(2004)
Mol Pharmacol
, vol.65
, pp. 999-1007
-
-
Carrier, E.J.1
Kearn, C.S.2
Barkmeier, A.J.3
Breese, N.M.4
Yang, W.5
Nithipatikom, K.6
-
90
-
-
84880172298
-
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease
-
3712244 23935251
-
More SV, Kumar H, Kim IS, Song SY, Choi DK. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediators Inflamm. 2013;2013:952375.
-
(2013)
Mediators Inflamm
, vol.2013
, pp. 952375
-
-
More, S.V.1
Kumar, H.2
Kim, I.S.3
Song, S.Y.4
Choi, D.K.5
-
91
-
-
33645106816
-
CB2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms
-
16553616
-
Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, Fredduzzi S, et al. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur J Neurosci. 2006;23:1530-8.
-
(2006)
Eur J Neurosci
, vol.23
, pp. 1530-1538
-
-
Beltramo, M.1
Bernardini, N.2
Bertorelli, R.3
Campanella, M.4
Nicolussi, E.5
Fredduzzi, S.6
-
92
-
-
78650388462
-
Central and peripheral sites of action for CB(2) receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats
-
3031063 1:CAS:528:DC%2BC3cXhs1eit77N 20880025
-
Hsieh GC, Pai M, Chandran P, Hooker BA, Zhu CZ, Salyers AK, et al. Central and peripheral sites of action for CB(2) receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Br J Pharmacol. 2011;162:428-40.
-
(2011)
Br J Pharmacol
, vol.162
, pp. 428-440
-
-
Hsieh, G.C.1
Pai, M.2
Chandran, P.3
Hooker, B.A.4
Zhu, C.Z.5
Salyers, A.K.6
-
93
-
-
0035218154
-
Actions of cannabinoid receptor ligands on rat cultured sensory neurones: Implications for antinociception
-
11114401
-
Ross RA, Coutts AA, McFarlane SM, Anavi-Goffer S, Irving AJ, Pertwee RG, et al. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology. 2001;40:221-32.
-
(2001)
Neuropharmacology
, vol.40
, pp. 221-232
-
-
Ross, R.A.1
Coutts, A.A.2
McFarlane, S.M.3
Anavi-Goffer, S.4
Irving, A.J.5
Pertwee, R.G.6
-
94
-
-
0037966402
-
Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats
-
12871657
-
Sokal DM, Elmes SJ, Kendall DA, Chapman V. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. Neuropharmacology. 2003;45:404-11.
-
(2003)
Neuropharmacology
, vol.45
, pp. 404-411
-
-
Sokal, D.M.1
Elmes, S.J.2
Kendall, D.A.3
Chapman, V.4
-
95
-
-
0029870716
-
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
-
39472 1:CAS:528:DyaK28XivVKrtbw%3D 8633002
-
Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, et al. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A. 1996;93:3984-9.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 3984-3989
-
-
Skaper, S.D.1
Buriani, A.2
Dal Toso, R.3
Petrelli, L.4
Romanello, S.5
Facci, L.6
-
96
-
-
84895752653
-
Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
-
3954486 1:CAS:528:DC%2BC2cXjsVentrs%3D 23808969
-
Rodriguez-Cueto C, Benito C, Fernandez-Ruiz J, Romero J, Hernandez-Galvez M, Gomez-Ruiz M. Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. Br J Pharmacol. 2014;171:1472-89.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 1472-1489
-
-
Rodriguez-Cueto, C.1
Benito, C.2
Fernandez-Ruiz, J.3
Romero, J.4
Hernandez-Galvez, M.5
Gomez-Ruiz, M.6
-
97
-
-
77951703978
-
Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry
-
20377992
-
Graham ES, Angel CE, Schwarcz LE, Dunbar PR, Glass M. Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry. Int J Immunopathol Pharmacol. 2010;23:25-34.
-
(2010)
Int J Immunopathol Pharmacol
, vol.23
, pp. 25-34
-
-
Graham, E.S.1
Angel, C.E.2
Schwarcz, L.E.3
Dunbar, P.R.4
Glass, M.5
-
98
-
-
58049170379
-
Endocannabinoid signaling in microglial cells
-
2654419 1:CAS:528:DC%2BD1MXhsVKhsg%3D%3D 18722389
-
Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology. 2009;56 Suppl 1:244-53.
-
(2009)
Neuropharmacology
, vol.56
, pp. 244-253
-
-
Stella, N.1
-
99
-
-
84857514914
-
Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide
-
3372829 1:CAS:528:DC%2BC38XjsVKqurc%3D 21951063
-
Merighi S, Gessi S, Varani K, Simioni C, Fazzi D, Mirandola P, et al. Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide. Br J Pharmacol. 2012;165:1773-88.
-
(2012)
Br J Pharmacol
, vol.165
, pp. 1773-1788
-
-
Merighi, S.1
Gessi, S.2
Varani, K.3
Simioni, C.4
Fazzi, D.5
Mirandola, P.6
-
100
-
-
0037440415
-
Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide
-
12509806
-
Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia. 2003;41:161-8.
-
(2003)
Glia
, vol.41
, pp. 161-168
-
-
Facchinetti, F.1
Del Giudice, E.2
Furegato, S.3
Passarotto, M.4
Leon, A.5
-
101
-
-
33244493807
-
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
-
16356641
-
Ashton JC, Friberg D, Darlington CL, Smith PF. Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett. 2006;396:113-6.
-
(2006)
Neurosci Lett
, vol.396
, pp. 113-116
-
-
Ashton, J.C.1
Friberg, D.2
Darlington, C.L.3
Smith, P.F.4
-
102
-
-
56549089453
-
Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus
-
18798269
-
Brusco A, Tagliaferro P, Saez T, Onaivi ES. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse. 2008;62:944-9.
-
(2008)
Synapse
, vol.62
, pp. 944-949
-
-
Brusco, A.1
Tagliaferro, P.2
Saez, T.3
Onaivi, E.S.4
-
103
-
-
0038678773
-
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
-
1573900 1:CAS:528:DC%2BD3sXlsVOiu7w%3D 12813001
-
Klegeris A, Bissonnette CJ, McGeer PL. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol. 2003;139:775-86.
-
(2003)
Br J Pharmacol
, vol.139
, pp. 775-786
-
-
Klegeris, A.1
Bissonnette, C.J.2
McGeer, P.L.3
-
104
-
-
0037442829
-
Nonpsychotropic cannabinoid receptors regulate microglial cell migration
-
12598628
-
Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, et al. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci. 2003;23:1398-405.
-
(2003)
J Neurosci
, vol.23
, pp. 1398-1405
-
-
Walter, L.1
Franklin, A.2
Witting, A.3
Wade, C.4
Xie, Y.5
Kunos, G.6
-
105
-
-
0348010292
-
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains
-
14657172
-
Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, et al. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci. 2003;23:11136-41.
-
(2003)
J Neurosci
, vol.23
, pp. 11136-11141
-
-
Benito, C.1
Nunez, E.2
Tolon, R.M.3
Carrier, E.J.4
Rabano, A.5
Hillard, C.J.6
-
106
-
-
3843066799
-
Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study
-
15266552
-
Nunez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonzalez S, et al. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse. 2004;53:208-13.
-
(2004)
Synapse
, vol.53
, pp. 208-213
-
-
Nunez, E.1
Benito, C.2
Pazos, M.R.3
Barbachano, A.4
Fajardo, O.5
Gonzalez, S.6
-
107
-
-
79953061968
-
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS
-
3137183 1:CAS:528:DC%2BC3MXjslOisLw%3D 21886591
-
Onaivi ES. Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS. Curr Neuropharmacol. 2011;9:205-8.
-
(2011)
Curr Neuropharmacol
, vol.9
, pp. 205-208
-
-
Onaivi, E.S.1
-
108
-
-
68749110973
-
Functional CB2 type cannabinoid receptors at CNS synapses
-
19616018
-
Morgan NH, Stanford IM, Woodhall GL. Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology. 2009;57:356-68.
-
(2009)
Neuropharmacology
, vol.57
, pp. 356-368
-
-
Morgan, N.H.1
Stanford, I.M.2
Woodhall, G.L.3
-
109
-
-
53549090175
-
Ultrastructural localization of neuronal brain CB2 cannabinoid receptors
-
18991892
-
Brusco A, Tagliaferro PA, Saez T, Onaivi ES. Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci. 2008;1139:450-7.
-
(2008)
Ann N y Acad Sci
, vol.1139
, pp. 450-457
-
-
Brusco, A.1
Tagliaferro, P.A.2
Saez, T.3
Onaivi, E.S.4
-
110
-
-
84857728457
-
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
-
den Boon FS, Chameau P, Schaafsma-Zhao Q, van Aken W, Bari M, Oddi S, et al. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci U S A. 2012;109:3534-9.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 3534-3539
-
-
Den Boon, F.S.1
Chameau, P.2
Schaafsma-Zhao, Q.3
Van Aken, W.4
Bari, M.5
Oddi, S.6
-
111
-
-
77957293518
-
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
-
20488834
-
Lanciego JL, Barroso-Chinea P, Rico AJ, Conte-Perales L, Callen L, Roda E, et al. Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis. J Psychopharmacol. 2011;25:97-104.
-
(2011)
J Psychopharmacol
, vol.25
, pp. 97-104
-
-
Lanciego, J.L.1
Barroso-Chinea, P.2
Rico, A.J.3
Conte-Perales, L.4
Callen, L.5
Roda, E.6
-
112
-
-
67649654149
-
Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats
-
19115376
-
Suarez J, Llorente R, Romero-Zerbo SY, Mateos B, Bermudez-Silva FJ, de Fonseca FR, et al. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus. 2009;19:623-32.
-
(2009)
Hippocampus
, vol.19
, pp. 623-632
-
-
Suarez, J.1
Llorente, R.2
Romero-Zerbo, S.Y.3
Mateos, B.4
Bermudez-Silva, F.J.5
De Fonseca, F.R.6
-
113
-
-
82755189177
-
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine
-
20980074 e421-416
-
Ternianov A, Perez-Ortiz JM, Solesio ME, Garcia-Gutierrez MS, Ortega-Alvaro A, Navarrete F, et al. Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. Neurobiol Aging. 2012;33:421. e421-416.
-
(2012)
Neurobiol Aging
, vol.33
, pp. 421
-
-
Ternianov, A.1
Perez-Ortiz, J.M.2
Solesio, M.E.3
Garcia-Gutierrez, M.S.4
Ortega-Alvaro, A.5
Navarrete, F.6
-
114
-
-
33845603466
-
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
-
17015409
-
Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzman M, Galve-Roperh I. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J. 2006;20:2405-7.
-
(2006)
FASEB J
, vol.20
, pp. 2405-2407
-
-
Palazuelos, J.1
Aguado, T.2
Egia, A.3
Mechoulam, R.4
Guzman, M.5
Galve-Roperh, I.6
-
115
-
-
69649091696
-
Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
-
2706932 19115380
-
Sagredo O, Gonzalez S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, et al. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia. 2009;57:1154-67.
-
(2009)
Glia
, vol.57
, pp. 1154-1167
-
-
Sagredo, O.1
Gonzalez, S.2
Aroyo, I.3
Pazos, M.R.4
Benito, C.5
Lastres-Becker, I.6
-
116
-
-
84907466163
-
CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?
-
25106425
-
Dhopeshwarkar A, Mackie K. CB2 Cannabinoid receptors as a therapeutic target-what does the future hold? Mol Pharmacol. 2014;86:430-7.
-
(2014)
Mol Pharmacol
, vol.86
, pp. 430-437
-
-
Dhopeshwarkar, A.1
Mackie, K.2
-
117
-
-
0034724402
-
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human
-
1:CAS:528:DC%2BD3cXitlWqu7w%3D 10725386
-
Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A. 2000;97:3655-60.
-
(2000)
Proc Natl Acad Sci U S A.
, vol.97
, pp. 3655-3660
-
-
Mezey, E.1
Toth, Z.E.2
Cortright, D.N.3
Arzubi, M.K.4
Krause, J.E.5
Elde, R.6
-
118
-
-
33646571242
-
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
-
16603318
-
Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience. 2006;139:1405-15.
-
(2006)
Neuroscience
, vol.139
, pp. 1405-1415
-
-
Cristino, L.1
De Petrocellis, L.2
Pryce, G.3
Baker, D.4
Guglielmotti, V.5
Di Marzo, V.6
-
119
-
-
79955732207
-
Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells
-
3087977 1:CAS:528:DC%2BC3MXkslSlurw%3D 21451044
-
Cavanaugh DJ, Chesler AT, Jackson AC, Sigal YM, Yamanaka H, Grant R, et al. Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci. 2011;31:5067-77.
-
(2011)
J Neurosci
, vol.31
, pp. 5067-5077
-
-
Cavanaugh, D.J.1
Chesler, A.T.2
Jackson, A.C.3
Sigal, Y.M.4
Yamanaka, H.5
Grant, R.6
-
120
-
-
58149461157
-
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels
-
18580871
-
Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, et al. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology. 2009;34:593-606.
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 593-606
-
-
Micale, V.1
Cristino, L.2
Tamburella, A.3
Petrosino, S.4
Leggio, G.M.5
Drago, F.6
-
121
-
-
0035946970
-
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues
-
11408034
-
Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, et al. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur J Pharmacol. 2001;420:123-31.
-
(2001)
Eur J Pharmacol
, vol.420
, pp. 123-131
-
-
Di Marzo, V.1
Lastres-Becker, I.2
Bisogno, T.3
De Petrocellis, L.4
Milone, A.5
Davis, J.B.6
-
122
-
-
1942503254
-
Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: In vivo and in vitro evidence
-
15064146
-
de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernandez-Ruiz J. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. Brain Res. 2004;1007:152-9.
-
(2004)
Brain Res
, vol.1007
, pp. 152-159
-
-
De Lago, E.1
De Miguel, R.2
Lastres-Becker, I.3
Ramos, J.A.4
Fernandez-Ruiz, J.5
-
123
-
-
35748973885
-
Novel cannabinoid receptors
-
2190013 1:CAS:528:DC%2BD2sXht1ejt7%2FN 17906678
-
Brown AJ. Novel cannabinoid receptors. Br J Pharmacol. 2007;152:567-75.
-
(2007)
Br J Pharmacol
, vol.152
, pp. 567-575
-
-
Brown, A.J.1
-
124
-
-
35649015179
-
The orphan receptor GPR55 is a novel cannabinoid receptor
-
2095107 1:CAS:528:DC%2BD2sXhtlCrsbnI 17876302
-
Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007;152:1092-101.
-
(2007)
Br J Pharmacol
, vol.152
, pp. 1092-1101
-
-
Ryberg, E.1
Larsson, N.2
Sjogren, S.3
Hjorth, S.4
Hermansson, N.O.5
Leonova, J.6
-
125
-
-
77952950690
-
Pharmacological characterization of GPR55, a putative cannabinoid receptor
-
2874616 1:CAS:528:DC%2BC3cXmsVeis7Y%3D 20298715
-
Sharir H, Abood ME. Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther. 2010;126:301-13.
-
(2010)
Pharmacol Ther
, vol.126
, pp. 301-313
-
-
Sharir, H.1
Abood, M.E.2
-
126
-
-
0033524644
-
Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain
-
9931487
-
Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, et al. Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res. 1999;64:193-8.
-
(1999)
Brain Res Mol Brain Res
, vol.64
, pp. 193-198
-
-
Sawzdargo, M.1
Nguyen, T.2
Lee, D.K.3
Lynch, K.R.4
Cheng, R.5
Heng, H.H.6
-
127
-
-
34548591720
-
Identification of GPR55 as a lysophosphatidylinositol receptor
-
17765871
-
Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun. 2007;362:928-34.
-
(2007)
Biochem Biophys Res Commun
, vol.362
, pp. 928-934
-
-
Oka, S.1
Nakajima, K.2
Yamashita, A.3
Kishimoto, S.4
Sugiura, T.5
-
128
-
-
40649102938
-
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
-
2268199 1:CAS:528:DC%2BD1cXis1yisr0%3D 18263732
-
Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A. 2008;105:2699-704.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 2699-2704
-
-
Lauckner, J.E.1
Jensen, J.B.2
Chen, H.Y.3
Lu, H.C.4
Hille, B.5
Mackie, K.6
-
129
-
-
0035545362
-
Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets
-
11860478
-
Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, et al. Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. Eur J Neurosci. 2001;14:1827-32.
-
(2001)
Eur J Neurosci
, vol.14
, pp. 1827-1832
-
-
Lastres-Becker, I.1
Cebeira, M.2
De Ceballos, M.L.3
Zeng, B.Y.4
Jenner, P.5
Ramos, J.A.6
-
130
-
-
21744461614
-
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease
-
15894565
-
van der Stelt M, Fox SH, Hill M, Crossman AR, Petrosino S, Di Marzo V, et al. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. FASEB J. 2005;19:1140-2.
-
(2005)
FASEB J
, vol.19
, pp. 1140-1142
-
-
Van Der Stelt, M.1
Fox, S.H.2
Hill, M.3
Crossman, A.R.4
Petrosino, S.5
Di Marzo, V.6
-
131
-
-
0034942985
-
Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates
-
Meschler JP, Howlett AC, Madras BK. Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates. Psychopharmacology (Berl). 2001;156:79-85.
-
(2001)
Psychopharmacology (Berl)
, vol.156
, pp. 79-85
-
-
Meschler, J.P.1
Howlett, A.C.2
Madras, B.K.3
-
133
-
-
84855806335
-
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
-
21459482 e621-628
-
Van Laere K, Casteels C, Lunskens S, Goffin K, Grachev ID, Bormans G, et al. Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo. Neurobiol Aging. 2012;33:620. e621-628.
-
(2012)
Neurobiol Aging
, vol.33
, pp. 620
-
-
Van Laere, K.1
Casteels, C.2
Lunskens, S.3
Goffin, K.4
Grachev, I.D.5
Bormans, G.6
-
134
-
-
0026602428
-
Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat
-
Prescott WR, Gold LH, Martin BR. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Psychopharmacology (Berl). 1992;107:117-24.
-
(1992)
Psychopharmacology (Berl)
, vol.107
, pp. 117-124
-
-
Prescott, W.R.1
Gold, L.H.2
Martin, B.R.3
-
135
-
-
0027444977
-
Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents
-
7906042
-
Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav. 1993;46:967-72.
-
(1993)
Pharmacol Biochem Behav
, vol.46
, pp. 967-972
-
-
Crawley, J.N.1
Corwin, R.L.2
Robinson, J.K.3
Felder, C.C.4
Devane, W.A.5
Axelrod, J.6
-
136
-
-
0029152832
-
The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway
-
8590042
-
Anderson LA, Anderson JJ, Chase TN, Walters JR. The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Brain Res. 1995;691:106-14.
-
(1995)
Brain Res
, vol.691
, pp. 106-114
-
-
Anderson, L.A.1
Anderson, J.J.2
Chase, T.N.3
Walters, J.R.4
-
137
-
-
0029011541
-
The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: Role of nigrostriatal dopaminergic neurons
-
7776829
-
Romero J, Garcia L, Cebeira M, Zadrozny D, Fernandez-Ruiz JJ, Ramos JA. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci. 1995;56:2033-40.
-
(1995)
Life Sci
, vol.56
, pp. 2033-2040
-
-
Romero, J.1
Garcia, L.2
Cebeira, M.3
Zadrozny, D.4
Fernandez-Ruiz, J.J.5
Ramos, J.A.6
-
138
-
-
67649843735
-
The endocannabinoid system as a target for the treatment of motor dysfunction
-
2697699 1:CAS:528:DC%2BD1MXltFSmur0%3D 19220290
-
Fernandez-Ruiz J. The endocannabinoid system as a target for the treatment of motor dysfunction. Br J Pharmacol. 2009;156:1029-40.
-
(2009)
Br J Pharmacol
, vol.156
, pp. 1029-1040
-
-
Fernandez-Ruiz, J.1
-
139
-
-
79953042017
-
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors
-
19419794
-
Perez-Rial S, Garcia-Gutierrez MS, Molina JA, Perez-Nievas BG, Ledent C, Leiva C, et al. Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors. Neurobiol Aging. 2011;32:631-45.
-
(2011)
Neurobiol Aging
, vol.32
, pp. 631-645
-
-
Perez-Rial, S.1
Garcia-Gutierrez, M.S.2
Molina, J.A.3
Perez-Nievas, B.G.4
Ledent, C.5
Leiva, C.6
-
140
-
-
78650726739
-
Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring
-
20969930
-
Shabani M, Hosseinmardi N, Haghani M, Shaibani V, Janahmadi M. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring. Neuroscience. 2011;172:139-52.
-
(2011)
Neuroscience
, vol.172
, pp. 139-152
-
-
Shabani, M.1
Hosseinmardi, N.2
Haghani, M.3
Shaibani, V.4
Janahmadi, M.5
-
141
-
-
0030887785
-
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
-
9106740
-
French ED, Dillon K, Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport. 1997;8:649-52.
-
(1997)
Neuroreport
, vol.8
, pp. 649-652
-
-
French, E.D.1
Dillon, K.2
Wu, X.3
-
142
-
-
0033816276
-
Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain
-
11041539
-
Melis M, Gessa GL, Diana M. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24:993-1006.
-
(2000)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.24
, pp. 993-1006
-
-
Melis, M.1
Gessa, G.L.2
Diana, M.3
-
143
-
-
38749125491
-
Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons
-
18164823
-
Morera-Herreras T, Ruiz-Ortega JA, Gomez-Urquijo S, Ugedo L. Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons. Neuroscience. 2008;151:817-23.
-
(2008)
Neuroscience
, vol.151
, pp. 817-823
-
-
Morera-Herreras, T.1
Ruiz-Ortega, J.A.2
Gomez-Urquijo, S.3
Ugedo, L.4
-
144
-
-
77958162949
-
Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of mu-opioid receptors and on dopamine axons in the mouse nucleus accumbens
-
2954666 1:CAS:528:DC%2BC3cXht1OgsbbI 20939059
-
Lane DA, Chan J, Lupica CR, Pickel VM. Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of mu-opioid receptors and on dopamine axons in the mouse nucleus accumbens. Synapse. 2010;64:886-97.
-
(2010)
Synapse
, vol.64
, pp. 886-897
-
-
Lane, D.A.1
Chan, J.2
Lupica, C.R.3
Pickel, V.M.4
-
145
-
-
0030761521
-
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
-
9197269
-
Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science. 1997;276:2048-50.
-
(1997)
Science
, vol.276
, pp. 2048-2050
-
-
Tanda, G.1
Pontieri, F.E.2
Di Chiara, G.3
-
146
-
-
33746541662
-
Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats
-
16805835
-
Solinas M, Justinova Z, Goldberg SR, Tanda G. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J Neurochem. 2006;98:408-19.
-
(2006)
J Neurochem
, vol.98
, pp. 408-419
-
-
Solinas, M.1
Justinova, Z.2
Goldberg, S.R.3
Tanda, G.4
-
147
-
-
77951949340
-
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
-
20461809
-
Pisani V, Moschella V, Bari M, Fezza F, Galati S, Bernardi G, et al. Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients. Mov Disord. 2010;25:920-4.
-
(2010)
Mov Disord
, vol.25
, pp. 920-924
-
-
Pisani, V.1
Moschella, V.2
Bari, M.3
Fezza, F.4
Galati, S.5
Bernardi, G.6
-
148
-
-
4644341666
-
Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms
-
15372606
-
Venderova K, Ruzicka E, Vorisek V, Visnovsky P. Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms. Mov Disord. 2004;19:1102-6.
-
(2004)
Mov Disord
, vol.19
, pp. 1102-1106
-
-
Venderova, K.1
Ruzicka, E.2
Vorisek, V.3
Visnovsky, P.4
-
149
-
-
0035846577
-
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
-
11739835
-
Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology. 2001;57:2108-11.
-
(2001)
Neurology
, vol.57
, pp. 2108-2111
-
-
Sieradzan, K.A.1
Fox, S.H.2
Hill, M.3
Dick, J.P.4
Crossman, A.R.5
Brotchie, J.M.6
-
150
-
-
20844441058
-
Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study
-
15477546
-
Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, et al. Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology. 2004;63:1245-50.
-
(2004)
Neurology
, vol.63
, pp. 1245-1250
-
-
Carroll, C.B.1
Bain, P.G.2
Teare, L.3
Liu, X.4
Joint, C.5
Wroath, C.6
-
151
-
-
2942597453
-
Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease
-
15190231
-
Mesnage V, Houeto JL, Bonnet AM, Clavier I, Arnulf I, Cattelin F, et al. Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease. Clin Neuropharmacol. 2004;27:108-10.
-
(2004)
Clin Neuropharmacol
, vol.27
, pp. 108-110
-
-
Mesnage, V.1
Houeto, J.L.2
Bonnet, A.M.3
Clavier, I.4
Arnulf, I.5
Cattelin, F.6
-
152
-
-
33846077467
-
Circuits and circuit disorders of the basal ganglia
-
17210805
-
DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol. 2007;64:20-4.
-
(2007)
Arch Neurol
, vol.64
, pp. 20-24
-
-
Delong, M.R.1
Wichmann, T.2
-
153
-
-
34247480145
-
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons
-
17408758
-
Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007;30:228-35.
-
(2007)
Trends Neurosci
, vol.30
, pp. 228-235
-
-
Surmeier, D.J.1
Ding, J.2
Day, M.3
Wang, Z.4
Shen, W.5
-
154
-
-
20744436550
-
Mechanisms for selection of basic motor programs-roles for the striatum and pallidum
-
15935487
-
Grillner S, Hellgren J, Menard A, Saitoh K, Wikstrom MA. Mechanisms for selection of basic motor programs-roles for the striatum and pallidum. Trends Neurosci. 2005;28:364-70.
-
(2005)
Trends Neurosci
, vol.28
, pp. 364-370
-
-
Grillner, S.1
Hellgren, J.2
Menard, A.3
Saitoh, K.4
Wikstrom, M.A.5
-
155
-
-
0035434121
-
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
-
11484001
-
Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci. 2001;2:577-88.
-
(2001)
Nat Rev Neurosci
, vol.2
, pp. 577-588
-
-
Bezard, E.1
Brotchie, J.M.2
Gross, C.E.3
-
156
-
-
75849140535
-
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth
-
2795506 1:CAS:528:DC%2BC3cXjvFGktrY%3D 19948956
-
Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault ML, O'Dowd BF, et al. Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci U S A. 2009;106:21377-82.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 21377-21382
-
-
Hasbi, A.1
Fan, T.2
Alijaniaram, M.3
Nguyen, T.4
Perreault, M.L.5
O'Dowd, B.F.6
-
157
-
-
84890454393
-
Heteromeric dopamine receptor signaling complexes: Emerging neurobiology and disease relevance
-
3857642 1:CAS:528:DC%2BC3sXhvFCqs73E 23774533
-
Perreault ML, Hasbi A, O'Dowd BF, George SR. Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacology. 2014;39:156-68.
-
(2014)
Neuropsychopharmacology
, vol.39
, pp. 156-168
-
-
Perreault, M.L.1
Hasbi, A.2
O'Dowd, B.F.3
George, S.R.4
-
158
-
-
34247469023
-
Dopamine-mediated regulation of corticostriatal synaptic plasticity
-
17367873
-
Calabresi P, Picconi B, Tozzi A, Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 2007;30:211-9.
-
(2007)
Trends Neurosci
, vol.30
, pp. 211-219
-
-
Calabresi, P.1
Picconi, B.2
Tozzi, A.3
Di Filippo, M.4
-
159
-
-
58049155757
-
Neurotrophic factors and structural plasticity in addiction
-
2635335 1:CAS:528:DC%2BD1MXhsVKhug%3D%3D 18647613
-
Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology. 2009;56 Suppl 1:73-82.
-
(2009)
Neuropharmacology
, vol.56
, pp. 73-82
-
-
Russo, S.J.1
Mazei-Robison, M.S.2
Ables, J.L.3
Nestler, E.J.4
-
160
-
-
0037303024
-
CB1 cannabinoid receptor signalling in Parkinson's disease
-
12550742
-
Brotchie JM. CB1 cannabinoid receptor signalling in Parkinson's disease. Curr Opin Pharmacol. 2003;3:54-61.
-
(2003)
Curr Opin Pharmacol
, vol.3
, pp. 54-61
-
-
Brotchie, J.M.1
-
161
-
-
0242583853
-
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: Implications for neurological and psychiatric disorders
-
14623357
-
van der Stelt M, Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol. 2003;480:133-50.
-
(2003)
Eur J Pharmacol
, vol.480
, pp. 133-150
-
-
Van Der Stelt, M.1
Di Marzo, V.2
-
162
-
-
81755181063
-
Bidirectional plasticity in striatonigral synapses: A switch to balance direct and indirect basal ganglia pathways
-
22101179
-
Aceves JJ, Rueda-Orozco PE, Hernandez-Martinez R, Galarraga E, Bargas J. Bidirectional plasticity in striatonigral synapses: a switch to balance direct and indirect basal ganglia pathways. Learn Mem. 2011;18:764-73.
-
(2011)
Learn Mem
, vol.18
, pp. 764-773
-
-
Aceves, J.J.1
Rueda-Orozco, P.E.2
Hernandez-Martinez, R.3
Galarraga, E.4
Bargas, J.5
-
163
-
-
34547569805
-
Endocannabinoids in basal ganglia circuits: Implications for Parkinson disease
-
17636069
-
Benarroch E. Endocannabinoids in basal ganglia circuits: implications for Parkinson disease. Neurology. 2007;69:306-9.
-
(2007)
Neurology
, vol.69
, pp. 306-309
-
-
Benarroch, E.1
-
164
-
-
80052521061
-
5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging the gap between serotonergic and glutamatergic mechanisms
-
21819982
-
Huot P, Brotchie JM. 5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms. Exp Neurol. 2011;231:195-8.
-
(2011)
Exp Neurol
, vol.231
, pp. 195-198
-
-
Huot, P.1
Brotchie, J.M.2
-
165
-
-
58149114715
-
Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity
-
2661034 19120438
-
Adermark L, Talani G, Lovinger DM. Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci. 2009;29:32-41.
-
(2009)
Eur J Neurosci
, vol.29
, pp. 32-41
-
-
Adermark, L.1
Talani, G.2
Lovinger, D.M.3
-
166
-
-
84866170442
-
Endocannabinoid-dopamine interactions in striatal synaptic plasticity
-
3329863 22529814
-
Mathur BN, Lovinger DM. Endocannabinoid-dopamine interactions in striatal synaptic plasticity. Front Pharmacol. 2012;3:66.
-
(2012)
Front Pharmacol
, vol.3
, pp. 66
-
-
Mathur, B.N.1
Lovinger, D.M.2
-
167
-
-
0037177601
-
Endocannabinoid signaling in the brain
-
11976437
-
Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science. 2002;296:678-82.
-
(2002)
Science
, vol.296
, pp. 678-682
-
-
Wilson, R.I.1
Nicoll, R.A.2
-
168
-
-
0034981628
-
Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum
-
11378162
-
Meschler JP, Howlett AC. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology. 2001;40:918-26.
-
(2001)
Neuropharmacology
, vol.40
, pp. 918-926
-
-
Meschler, J.P.1
Howlett, A.C.2
-
169
-
-
0031047273
-
Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
-
9472392
-
Glass M, Dragunow M, Faull RL. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 1997;77:299-318.
-
(1997)
Neuroscience
, vol.77
, pp. 299-318
-
-
Glass, M.1
Dragunow, M.2
Faull, R.L.3
-
170
-
-
40849137554
-
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
-
18262573
-
Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, et al. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology. 2008;54:815-23.
-
(2008)
Neuropharmacology
, vol.54
, pp. 815-823
-
-
Marcellino, D.1
Carriba, P.2
Filip, M.3
Borgkvist, A.4
Frankowska, M.5
Bellido, I.6
-
171
-
-
1342344556
-
D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor
-
14634050
-
Jarrahian A, Watts VJ, Barker EL. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther. 2004;308:880-6.
-
(2004)
J Pharmacol Exp Ther
, vol.308
, pp. 880-886
-
-
Jarrahian, A.1
Watts, V.J.2
Barker, E.L.3
-
172
-
-
33144488036
-
Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens
-
1:CAS:528:DC%2BD28XitF2gsro%3D 16440297
-
Pickel VM, Chan J, Kearn CS, Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol. 2006;495:299-313.
-
(2006)
J Comp Neurol
, vol.495
, pp. 299-313
-
-
Pickel, V.M.1
Chan, J.2
Kearn, C.S.3
Mackie, K.4
-
173
-
-
17844410926
-
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?
-
15710746
-
Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol. 2005;67:1697-704.
-
(2005)
Mol Pharmacol
, vol.67
, pp. 1697-1704
-
-
Kearn, C.S.1
Blake-Palmer, K.2
Daniel, E.3
Mackie, K.4
Glass, M.5
-
174
-
-
33846908287
-
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
-
17287809
-
Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature. 2007;445:643-7.
-
(2007)
Nature
, vol.445
, pp. 643-647
-
-
Kreitzer, A.C.1
Malenka, R.C.2
-
175
-
-
84862292337
-
Cannabinoid receptors CB1 and CB2 form functional heteromers in brain
-
3375509 1:CAS:528:DC%2BC38Xos1Cksrk%3D 22532560
-
Callen L, Moreno E, Barroso-Chinea P, Moreno-Delgado D, Cortes A, Mallol J, et al. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. J Biol Chem. 2012;287:20851-65.
-
(2012)
J Biol Chem
, vol.287
, pp. 20851-20865
-
-
Callen, L.1
Moreno, E.2
Barroso-Chinea, P.3
Moreno-Delgado, D.4
Cortes, A.5
Mallol, J.6
-
176
-
-
84892589625
-
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta
-
24334069
-
Freestone PS, Guatteo E, Piscitelli F, di Marzo V, Lipski J, Mercuri NB. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta. Neuropharmacology. 2014;79:467-75.
-
(2014)
Neuropharmacology
, vol.79
, pp. 467-475
-
-
Freestone, P.S.1
Guatteo, E.2
Piscitelli, F.3
Di Marzo, V.4
Lipski, J.5
Mercuri, N.B.6
-
177
-
-
33846258769
-
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors
-
16760924
-
Marinelli S, Di Marzo V, Florenzano F, Fezza F, Viscomi MT, van der Stelt M, et al. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology. 2007;32:298-308.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 298-308
-
-
Marinelli, S.1
Di Marzo, V.2
Florenzano, F.3
Fezza, F.4
Viscomi, M.T.5
Van Der Stelt, M.6
-
178
-
-
79951560770
-
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release
-
20711816
-
Bari M, Bonifacino T, Milanese M, Spagnuolo P, Zappettini S, Battista N, et al. The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release. Cell Mol Life Sci. 2011;68:833-45.
-
(2011)
Cell Mol Life Sci
, vol.68
, pp. 833-845
-
-
Bari, M.1
Bonifacino, T.2
Milanese, M.3
Spagnuolo, P.4
Zappettini, S.5
Battista, N.6
-
179
-
-
78649369301
-
Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens
-
3092590 1:CAS:528:DC%2BC3cXhsVWmurjP 21076424
-
Grueter BA, Brasnjo G, Malenka RC. Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat Neurosci. 2010;13:1519-25.
-
(2010)
Nat Neurosci
, vol.13
, pp. 1519-1525
-
-
Grueter, B.A.1
Brasnjo, G.2
Malenka, R.C.3
-
180
-
-
33645062930
-
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias
-
Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain. 2006;129:1059-69.
-
(2006)
Brain
, vol.129
, pp. 1059-1069
-
-
Morgante, F.1
Espay, A.J.2
Gunraj, C.3
Lang, A.E.4
Chen, R.5
-
181
-
-
0037407907
-
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
-
12665799
-
Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci. 2003;6:501-6.
-
(2003)
Nat Neurosci
, vol.6
, pp. 501-506
-
-
Picconi, B.1
Centonze, D.2
Hakansson, K.3
Bernardi, G.4
Greengard, P.5
Fisone, G.6
-
182
-
-
0036233834
-
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
-
11976704
-
Gerdeman GL, Ronesi J, Lovinger DM. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci. 2002;5:446-51.
-
(2002)
Nat Neurosci
, vol.5
, pp. 446-451
-
-
Gerdeman, G.L.1
Ronesi, J.2
Lovinger, D.M.3
-
183
-
-
27744517743
-
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum
-
16280591
-
Kreitzer AC, Malenka RC. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci. 2005;25:10537-45.
-
(2005)
J Neurosci
, vol.25
, pp. 10537-10545
-
-
Kreitzer, A.C.1
Malenka, R.C.2
-
184
-
-
1242341965
-
Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport
-
14973237
-
Ronesi J, Gerdeman GL, Lovinger DM. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci. 2004;24:1673-9.
-
(2004)
J Neurosci
, vol.24
, pp. 1673-1679
-
-
Ronesi, J.1
Gerdeman, G.L.2
Lovinger, D.M.3
-
185
-
-
84856247652
-
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance
-
22231426
-
Nazzaro C, Greco B, Cerovic M, Baxter P, Rubino T, Trusel M, et al. SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat Neurosci. 2012;15:284-93.
-
(2012)
Nat Neurosci
, vol.15
, pp. 284-293
-
-
Nazzaro, C.1
Greco, B.2
Cerovic, M.3
Baxter, P.4
Rubino, T.5
Trusel, M.6
-
186
-
-
79952654936
-
Homeostatic changes of the endocannabinoid system in Parkinson's disease
-
21412829
-
Pisani V, Madeo G, Tassone A, Sciamanna G, Maccarrone M, Stanzione P, et al. Homeostatic changes of the endocannabinoid system in Parkinson's disease. Mov Disord. 2011;26:216-22.
-
(2011)
Mov Disord
, vol.26
, pp. 216-222
-
-
Pisani, V.1
Madeo, G.2
Tassone, A.3
Sciamanna, G.4
Maccarrone, M.5
Stanzione, P.6
-
187
-
-
52949114944
-
The endocannabinoid system in Parkinson's disease
-
18781984
-
Di Filippo M, Picconi B, Tozzi A, Ghiglieri V, Rossi A, Calabresi P. The endocannabinoid system in Parkinson's disease. Curr Pharm Des. 2008;14:2337-47.
-
(2008)
Curr Pharm des
, vol.14
, pp. 2337-2347
-
-
Di Filippo, M.1
Picconi, B.2
Tozzi, A.3
Ghiglieri, V.4
Rossi, A.5
Calabresi, P.6
-
188
-
-
3242810641
-
Immunolocalization of CB1 receptor in rat striatal neurons: A confocal microscopy study
-
15236348
-
Fusco FR, Martorana A, Giampa C, De March Z, Farini D, D'Angelo V, et al. Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study. Synapse. 2004;53:159-67.
-
(2004)
Synapse
, vol.53
, pp. 159-167
-
-
Fusco, F.R.1
Martorana, A.2
Giampa, C.3
De March, Z.4
Farini, D.5
D'Angelo, V.6
-
189
-
-
79551716951
-
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia
-
21183486
-
Picconi B, Bagetta V, Ghiglieri V, Paille V, Di Filippo M, Pendolino V, et al. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain. 2011;134:375-87.
-
(2011)
Brain
, vol.134
, pp. 375-387
-
-
Picconi, B.1
Bagetta, V.2
Ghiglieri, V.3
Paille, V.4
Di Filippo, M.5
Pendolino, V.6
-
190
-
-
0033119685
-
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression
-
10087063
-
Calabresi P, Gubellini P, Centonze D, Sancesario G, Morello M, Giorgi M, et al. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J Neurosci. 1999;19:2489-99.
-
(1999)
J Neurosci
, vol.19
, pp. 2489-2499
-
-
Calabresi, P.1
Gubellini, P.2
Centonze, D.3
Sancesario, G.4
Morello, M.5
Giorgi, M.6
-
191
-
-
0032451280
-
Brain cannabinoid systems as targets for the therapy of neurological disorders
-
9974182
-
Consroe P. Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiol Dis. 1998;5:534-51.
-
(1998)
Neurobiol Dis
, vol.5
, pp. 534-551
-
-
Consroe, P.1
-
193
-
-
43449092524
-
The cannabinoid system in Parkinson's disease: Multiple targets to motor effects
-
18433745
-
Papa SM. The cannabinoid system in Parkinson's disease: multiple targets to motor effects. Exp Neurol. 2008;211:334-8.
-
(2008)
Exp Neurol
, vol.211
, pp. 334-338
-
-
Papa, S.M.1
-
194
-
-
84905728529
-
Dyskinesia in Parkinson's disease: Mechanisms and current non-pharmacological interventions
-
24773031
-
Heumann R, Moratalla R, Herrero MT, Chakrabarty K, Drucker-Colin R, Garcia-Montes JR, et al. Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. J Neurochem. 2014;130:472-89.
-
(2014)
J Neurochem
, vol.130
, pp. 472-489
-
-
Heumann, R.1
Moratalla, R.2
Herrero, M.T.3
Chakrabarty, K.4
Drucker-Colin, R.5
Garcia-Montes, J.R.6
-
195
-
-
34047181576
-
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum
-
17250681
-
Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, et al. CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem. 2007;101:389-96.
-
(2007)
J Neurochem
, vol.101
, pp. 389-396
-
-
Price, D.A.1
Owens, W.A.2
Gould, G.G.3
Frazer, A.4
Roberts, J.L.5
Daws, L.C.6
-
196
-
-
84887514200
-
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson s disease
-
24140894
-
Gonzalez-Aparicio R, Moratalla R. Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson s disease. Neurobiol Dis. 2014;62:416-25.
-
(2014)
Neurobiol Dis
, vol.62
, pp. 416-425
-
-
Gonzalez-Aparicio, R.1
Moratalla, R.2
-
197
-
-
0031265644
-
The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease
-
9398468
-
Maneuf YP, Crossman AR, Brotchie JM. The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease. Exp Neurol. 1997;148:265-70.
-
(1997)
Exp Neurol
, vol.148
, pp. 265-270
-
-
Maneuf, Y.P.1
Crossman, A.R.2
Brotchie, J.M.3
-
198
-
-
70349109586
-
Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice
-
19733208
-
Huang P, Liu-Chen LY, Unterwald EM, Cowan A. Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice. Neurosci Lett. 2009;465:66-70.
-
(2009)
Neurosci Lett
, vol.465
, pp. 66-70
-
-
Huang, P.1
Liu-Chen, L.Y.2
Unterwald, E.M.3
Cowan, A.4
-
199
-
-
14744301757
-
Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism
-
15755685
-
Fernandez-Espejo E, Caraballo I, de Fonseca FR, El Banoua F, Ferrer B, Flores JA, et al. Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism. Neurobiol Dis. 2005;18:591-601.
-
(2005)
Neurobiol Dis
, vol.18
, pp. 591-601
-
-
Fernandez-Espejo, E.1
Caraballo, I.2
De Fonseca, F.R.3
El Banoua, F.4
Ferrer, B.5
Flores, J.A.6
-
200
-
-
33644952242
-
Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease
-
Gonzalez S, Scorticati C, Garcia-Arensibia M, de Miguel R, Ramos JA, Vernandez-Ruiz J. Effects of rimnabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.0Brain Res. 2006;1073-1074:209-19.
-
(2006)
Brain Res
, vol.1073-1074
, pp. 209-219
-
-
Gonzalez, S.1
Scorticati, C.2
Garcia-Arencibia, M.3
De Miguel, R.4
Ramos, J.A.5
Fernandez-Ruiz, J.6
-
201
-
-
43549124297
-
Enhanced striatal glutamate releasu after the administration of ri}onabant to 6-hydroxydopamine-lesioned rats
-
18457923
-
Garcia-Arencibia M, Ferraro L, Tanganelli S, Fernandez-Ruiz J. Enhanced striatal glutamqte release after the administration of rimonabant to 6-hydroxyd pamine-lesioned rats. Neurosciett. 2008;438:10-3.
-
(2008)
Neurosci Lett
, vol.438
, pp. 10-13
-
-
Garcia-Aruncibia, M.1
Ferraro, L.2
Tanganelli, S.3
Fernandez-Ruiz, J.4
-
202
-
-
0034027839
-
Clinisal pharmacology of levodopa-induced dyskinesia
-
10762144 discussion S164-166
-
Nutt JG. Clinical pharmacology of levodopa-induced dyskinesia. An~ Neurol. 2000;47:S160-4. discussion S164-166.
-
(2000)
Ann Neurol
, vol.47
, pp. 160-164
-
-
Nutt, J.G.1
-
203
-
-
0033695441
-
Levodopa motor complycations in Parkinson's disease
-
11052214
-
Obeso JA, Olanow CW, Nutt JG. Levodopa motor complications in Parkinson's disease. Trends Neurosci. 2000;23:S2-7.
-
(2000)
Trends Neurosci
, vol.23
, pp. 2-7
-
-
Obeso, J.A.1
Olanow, C.W.2
Nutt, J.G.3
-
204
-
-
0141481993
-
Effects of Levodopa on Endocqnnabinoid Levels in Rat Basal Gqnglia: Implications for the Treqtment of Levodopa-induced Dyski~esias
-
14511339
-
Ferrer B, Asbrock N, Kathuria S Piomelli D, Giuffrida A. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci. 2003;18:1607-14.
-
(2003)
Eur J Neurosci
, vol.18
, pp. 1607-1614
-
-
Ferrer, B.1
Asbrock, N.2
Kathuria, S.3
Piomelli, D.4
Giuffrida, A.5
-
205
-
-
0036868444
-
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
-
12465055
-
Fox SH, Henry B, Hill M, Crossman A, Brotchie J. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord. 2002;17:1180-7.
-
(2002)
Mov Disord
, vol.17
, pp. 1180-1187
-
-
Fox, S.H.1
Henry, B.2
Hill, M.3
Crossman, A.4
Brotchie, J.5
-
206
-
-
34548848043
-
Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys
-
17630359
-
Cao X, Liang L, Hadcock JR, Iredale PA, Griffith DA, Menniti FS, et al. Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys. J Pharmacol Exp Ther. 2007;323:318-26.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 318-326
-
-
Cao, X.1
Liang, L.2
Hadcock, J.R.3
Iredale, P.A.4
Griffith, D.A.5
Menniti, F.S.6
-
207
-
-
50449099017
-
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: New aspects in the pathogenetic mechanisms
-
18717735
-
Giorgi M, D'Angelo V, Esposito Z, Nuccetelli V, Sorge R, Martorana A, et al. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Eur J Neurosci. 2008;28:941-50.
-
(2008)
Eur J Neurosci
, vol.28
, pp. 941-950
-
-
Giorgi, M.1
D'Angelo, V.2
Esposito, Z.3
Nuccetelli, V.4
Sorge, R.5
Martorana, A.6
-
208
-
-
78249271694
-
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
-
20882603
-
Rylander D, Parent M, O'Sullivan SS, Dovero S, Lees AJ, Bezard E, et al. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol. 2010;68:619-28.
-
(2010)
Ann Neurol
, vol.68
, pp. 619-628
-
-
Rylander, D.1
Parent, M.2
O'Sullivan, S.S.3
Dovero, S.4
Lees, A.J.5
Bezard, E.6
-
209
-
-
34447627504
-
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
-
17452372
-
Carta M, Carlsson T, Kirik D, Bjorklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain. 2007;130:1819-33.
-
(2007)
Brain
, vol.130
, pp. 1819-1833
-
-
Carta, M.1
Carlsson, T.2
Kirik, D.3
Bjorklund, A.4
-
210
-
-
84856304569
-
RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits
-
3269032 1:CAS:528:DC%2BC38XhsFSitr4%3D 22284188
-
Lerner TN, Kreitzer AC. RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron. 2012;73:347-59.
-
(2012)
Neuron
, vol.73
, pp. 347-359
-
-
Lerner, T.N.1
Kreitzer, A.C.2
-
211
-
-
0037996964
-
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors
-
12716921
-
Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G, et al. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci. 2003;23:3136-44.
-
(2003)
J Neurosci
, vol.23
, pp. 3136-3144
-
-
Marinelli, S.1
Di Marzo, V.2
Berretta, N.3
Matias, I.4
Maccarrone, M.5
Bernardi, G.6
-
212
-
-
75549087003
-
Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses
-
20081851
-
Lourenco J, Cannich A, Carta M, Coussen F, Mulle C, Marsicano G. Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. Nat Neurosci. 2010;13:197-204.
-
(2010)
Nat Neurosci
, vol.13
, pp. 197-204
-
-
Lourenco, J.1
Cannich, A.2
Carta, M.3
Coussen, F.4
Mulle, C.5
Marsicano, G.6
-
213
-
-
0037104758
-
Experimental parkinsonism alters endocannabinoid degradation: Implications for striatal glutamatergic transmission
-
12177188
-
Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, et al. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci. 2002;22:6900-7.
-
(2002)
J Neurosci
, vol.22
, pp. 6900-6907
-
-
Gubellini, P.1
Picconi, B.2
Bari, M.3
Battista, N.4
Calabresi, P.5
Centonze, D.6
-
214
-
-
77950935474
-
MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism
-
2849839 1:CAS:528:DC%2BC3cXksVeksL0%3D 20079362
-
Paquette MA, Anderson AM, Lewis JR, Meshul CK, Johnson SW, Paul Berger S. MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism. Neuropharmacology. 2010;58:1002-8.
-
(2010)
Neuropharmacology
, vol.58
, pp. 1002-1008
-
-
Paquette, M.A.1
Anderson, A.M.2
Lewis, J.R.3
Meshul, C.K.4
Johnson, S.W.5
Paul Berger, S.6
-
215
-
-
77953184604
-
Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
-
20198649
-
Wolf E, Seppi K, Katzenschlager R, Hochschorner G, Ransmayr G, Schwingenschuh P, et al. Long-term antidyskinetic efficacy of amantadine in Parkinson's disease. Mov Disord. 2010;25:1357-63.
-
(2010)
Mov Disord
, vol.25
, pp. 1357-1363
-
-
Wolf, E.1
Seppi, K.2
Katzenschlager, R.3
Hochschorner, G.4
Ransmayr, G.5
Schwingenschuh, P.6
-
216
-
-
79953647380
-
Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias
-
21371994
-
Ahmed I, Bose SK, Pavese N, Ramlackhansingh A, Turkheimer F, Hotton G, et al. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. Brain. 2011;134:979-86.
-
(2011)
Brain
, vol.134
, pp. 979-986
-
-
Ahmed, I.1
Bose, S.K.2
Pavese, N.3
Ramlackhansingh, A.4
Turkheimer, F.5
Hotton, G.6
-
217
-
-
0026081175
-
Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids
-
1649415
-
Pertwee RG, Wickens AP. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology. 1991;30:237-44.
-
(1991)
Neuropharmacology
, vol.30
, pp. 237-244
-
-
Pertwee, R.G.1
Wickens, A.P.2
-
218
-
-
77952640781
-
Adenosine-cannabinoid receptor interactions. Implications for striatal function
-
2931547 1:CAS:528:DC%2BC3cXpslyrur8%3D 20590556
-
Ferre S, Lluis C, Justinova Z, Quiroz C, Orru M, Navarro G, et al. Adenosine-cannabinoid receptor interactions. Implications for striatal function. Br J Pharmacol. 2010;160:443-53.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 443-453
-
-
Ferre, S.1
Lluis, C.2
Justinova, Z.3
Quiroz, C.4
Orru, M.5
Navarro, G.6
-
219
-
-
2942564063
-
Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model
-
15193294
-
El-Banoua F, Caraballo I, Flores JA, Galan-Rodriguez B, Fernandez-Espejo E. Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model. Neurobiol Dis. 2004;16:377-85.
-
(2004)
Neurobiol Dis
, vol.16
, pp. 377-385
-
-
El-Banoua, F.1
Caraballo, I.2
Flores, J.A.3
Galan-Rodriguez, B.4
Fernandez-Espejo, E.5
-
220
-
-
0033614984
-
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
-
10440374
-
Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400:452-7.
-
(1999)
Nature
, vol.400
, pp. 452-457
-
-
Zygmunt, P.M.1
Petersson, J.2
Andersson, D.A.3
Chuang, H.4
Sorgard, M.5
Di Marzo, V.6
-
221
-
-
0033984992
-
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
-
1571834 1:CAS:528:DC%2BD3cXpslylug%3D%3D 10694225
-
Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol. 2000;129:227-30.
-
(2000)
Br J Pharmacol
, vol.129
, pp. 227-230
-
-
Smart, D.1
Gunthorpe, M.J.2
Jerman, J.C.3
Nasir, S.4
Gray, J.5
Muir, A.I.6
-
222
-
-
84980052949
-
TRPV1: A stress response protein in the central nervous system
-
3560445 22737633
-
Ho KW, Ward NJ, Calkins DJ. TRPV1: a stress response protein in the central nervous system. Am J Neurodegener Dis. 2012;1:1-14.
-
(2012)
Am J Neurodegener Dis
, vol.1
, pp. 1-14
-
-
Ho, K.W.1
Ward, N.J.2
Calkins, D.J.3
-
223
-
-
35348938494
-
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors
-
2128772 1:CAS:528:DC%2BD2sXht1anurvK 17900568
-
Morgese MG, Cassano T, Cuomo V, Giuffrida A. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. Exp Neurol. 2007;208:110-9.
-
(2007)
Exp Neurol
, vol.208
, pp. 110-119
-
-
Morgese, M.G.1
Cassano, T.2
Cuomo, V.3
Giuffrida, A.4
-
224
-
-
0030777012
-
The capsaicin receptor: A heat-activated ion channel in the pain pathway
-
9349813
-
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816-24.
-
(1997)
Nature
, vol.389
, pp. 816-824
-
-
Caterina, M.J.1
Schumacher, M.A.2
Tominaga, M.3
Rosen, T.A.4
Levine, J.D.5
Julius, D.6
-
225
-
-
17444370570
-
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
-
15837565
-
Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernandez-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol Dis. 2005;19:96-107.
-
(2005)
Neurobiol Dis
, vol.19
, pp. 96-107
-
-
Lastres-Becker, I.1
Molina-Holgado, F.2
Ramos, J.A.3
Mechoulam, R.4
Fernandez-Ruiz, J.5
-
226
-
-
0344873175
-
Anandamide and vanilloid TRPV1 receptors
-
1574087 1:CAS:528:DC%2BD3sXps1eksr4%3D 14517174
-
Ross RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol. 2003;140:790-801.
-
(2003)
Br J Pharmacol
, vol.140
, pp. 790-801
-
-
Ross, R.A.1
-
227
-
-
33747061265
-
A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats
-
16806299
-
Lee J, Di Marzo V, Brotchie JM. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats. Neuropharmacology. 2006;51:557-65.
-
(2006)
Neuropharmacology
, vol.51
, pp. 557-565
-
-
Lee, J.1
Di Marzo, V.2
Brotchie, J.M.3
-
228
-
-
12744280682
-
Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro
-
15659603
-
Kim SR, Lee DY, Chung ES, Oh UT, Kim SU, Jin BK. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J Neurosci. 2005;25:662-71.
-
(2005)
J Neurosci
, vol.25
, pp. 662-671
-
-
Kim, S.R.1
Lee, D.Y.2
Chung, E.S.3
Oh, U.T.4
Kim, S.U.5
Jin, B.K.6
-
229
-
-
65049090530
-
Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide
-
19289116
-
Garcia Mdel C, Adler-Graschinsky E, Celuch SM. Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide. Eur J Pharmacol. 2009;610:75-80.
-
(2009)
Eur J Pharmacol
, vol.610
, pp. 75-80
-
-
Garcia Mdel, C.1
Adler-Graschinsky, E.2
Celuch, S.M.3
-
231
-
-
33746621595
-
The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin
-
1544096 1:CAS:528:DC%2BD28XnvVars7s%3D 16849427
-
Patwardhan AM, Jeske NA, Price TJ, Gamper N, Akopian AN, Hargreaves KM. The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc Natl Acad Sci U S A. 2006;103:11393-8.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 11393-11398
-
-
Patwardhan, A.M.1
Jeske, N.A.2
Price, T.J.3
Gamper, N.4
Akopian, A.N.5
Hargreaves, K.M.6
-
232
-
-
18144385088
-
Evidence for novel cannabinoid receptors
-
15866316
-
Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Mo FM, et al. Evidence for novel cannabinoid receptors. Pharmacol Ther. 2005;106:133-45.
-
(2005)
Pharmacol Ther
, vol.106
, pp. 133-145
-
-
Begg, M.1
Pacher, P.2
Batkai, S.3
Osei-Hyiaman, D.4
Offertaler, L.5
Mo, F.M.6
-
233
-
-
84855339807
-
Effects on cell viability
-
16596790
-
Guzman M. Effects on cell viability. Handb Exp Pharmacol. 2005;168:627-42.
-
(2005)
Handb Exp Pharmacol
, vol.168
, pp. 627-642
-
-
Guzman, M.1
-
234
-
-
29344445590
-
Cannabinoids in neurodegeneration and neuroprotection
-
R. Mechoulam (eds) Springer Science & Business Media Birkhäuser Basel
-
Javier Fernández-Ruiz SG, Julián R, José Antonio R. Cannabinoids in neurodegeneration and neuroprotection. In: Mechoulam R, editor. Cannabinoids as Therapeutics. Birkhäuser Basel: Springer Science & Business Media; 2005. p. 79-109.
-
(2005)
Cannabinoids As Therapeutics
, pp. 79-109
-
-
Javier Fernández-Ruiz, S.G.1
Julián, R.2
José Antonio, R.3
-
235
-
-
38449086056
-
Endocannabinoids and traumatic brain injury
-
17952651
-
Mechoulam R, Shohami E. Endocannabinoids and traumatic brain injury. Mol Neurobiol. 2007;36:68-74.
-
(2007)
Mol Neurobiol
, vol.36
, pp. 68-74
-
-
Mechoulam, R.1
Shohami, E.2
-
236
-
-
84868128338
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities
-
3481523 1:CAS:528:DC%2BC38XhvVKgtL3L 23108552
-
Pertwee RG. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci. 2012;367:3353-63.
-
(2012)
Philos Trans R Soc Lond B Biol Sci
, vol.367
, pp. 3353-3363
-
-
Pertwee, R.G.1
-
238
-
-
52949119940
-
Role of cannabinoids and endocannabinoids in cerebral ischemia
-
2581413 1:CAS:528:DC%2BD1cXht1SgtbbO 18781985
-
Hillard CJ. Role of cannabinoids and endocannabinoids in cerebral ischemia. Curr Pharm Des. 2008;14:2347-61.
-
(2008)
Curr Pharm des
, vol.14
, pp. 2347-2361
-
-
Hillard, C.J.1
-
239
-
-
33845959991
-
Cannabinoid CB2 receptor: A new target for controlling neural cell survival?
-
17141334
-
Fernandez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M. Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci. 2007;28:39-45.
-
(2007)
Trends Pharmacol Sci
, vol.28
, pp. 39-45
-
-
Fernandez-Ruiz, J.1
Romero, J.2
Velasco, G.3
Tolon, R.M.4
Ramos, J.A.5
Guzman, M.6
-
240
-
-
41749084838
-
Cannabinoids and neuroprotection in motor-related disorders
-
18220777
-
de Lago E, Fernandez-Ruiz J. Cannabinoids and neuroprotection in motor-related disorders. CNS Neurol Disord Drug Targets. 2007;6:377-87.
-
(2007)
CNS Neurol Disord Drug Targets
, vol.6
, pp. 377-387
-
-
De Lago, E.1
Fernandez-Ruiz, J.2
-
243
-
-
84861040660
-
Update on the role of cannabinoid receptors after ischemic stroke
-
3337695 22577257
-
Capettini LS, Savergnini SQ, da Silva RF, Stergiopulos N, Santos RA, Mach F, et al. Update on the role of cannabinoid receptors after ischemic stroke. Mediators Inflamm. 2012;2012:824093.
-
(2012)
Mediators Inflamm
, vol.2012
, pp. 824093
-
-
Capettini, L.S.1
Savergnini, S.Q.2
Da Silva, R.F.3
Stergiopulos, N.4
Santos, R.A.5
Mach, F.6
-
244
-
-
84949116595
-
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain
-
25446347
-
Rangel-Lopez E, Colin-Gonzalez AL, Paz-Loyola AL, Pinzon E, Torres I, Serratos IN, et al. Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain. Neuroscience. 2015;285:97-106.
-
(2015)
Neuroscience
, vol.285
, pp. 97-106
-
-
Rangel-Lopez, E.1
Colin-Gonzalez, A.L.2
Paz-Loyola, A.L.3
Pinzon, E.4
Torres, I.5
Serratos, I.N.6
-
245
-
-
84873082457
-
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects
-
23296873
-
Zogopoulos P, Vasileiou I, Patsouris E, Theocharis S. The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects. J Appl Toxicol. 2013;33:246-64.
-
(2013)
J Appl Toxicol
, vol.33
, pp. 246-264
-
-
Zogopoulos, P.1
Vasileiou, I.2
Patsouris, E.3
Theocharis, S.4
-
246
-
-
84906076125
-
Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier
-
24929655
-
Vendel E, de Lange EC. Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier. Neuromolecular Med. 2014;16:620-42.
-
(2014)
Neuromolecular Med
, vol.16
, pp. 620-642
-
-
Vendel, E.1
De Lange, E.C.2
-
247
-
-
33846047809
-
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain
-
17123706
-
Ashton JC, Rahman RM, Nair SM, Sutherland BA, Glass M, Appleton I. Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain. Neurosci Lett. 2007;412:114-7.
-
(2007)
Neurosci Lett
, vol.412
, pp. 114-117
-
-
Ashton, J.C.1
Rahman, R.M.2
Nair, S.M.3
Sutherland, B.A.4
Glass, M.5
Appleton, I.6
-
248
-
-
70350697391
-
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
-
19805493
-
Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, et al. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain. 2009;132:3152-64.
-
(2009)
Brain
, vol.132
, pp. 3152-3164
-
-
Palazuelos, J.1
Aguado, T.2
Pazos, M.R.3
Julien, B.4
Carrasco, C.5
Resel, E.6
-
249
-
-
37849049077
-
Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome
-
18068305
-
Nunez E, Benito C, Tolon RM, Hillard CJ, Griffin WS, Romero J. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome. Neuroscience. 2008;151:104-10.
-
(2008)
Neuroscience
, vol.151
, pp. 104-110
-
-
Nunez, E.1
Benito, C.2
Tolon, R.M.3
Hillard, C.J.4
Griffin, W.S.5
Romero, J.6
-
250
-
-
33847420442
-
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
-
17329437
-
Benito C, Romero JP, Tolon RM, Clemente D, Docagne F, Hillard CJ, et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci. 2007;27:2396-402.
-
(2007)
J Neurosci
, vol.27
, pp. 2396-2402
-
-
Benito, C.1
Romero, J.P.2
Tolon, R.M.3
Clemente, D.4
Docagne, F.5
Hillard, C.J.6
-
251
-
-
33645224970
-
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
-
1413551 16512913
-
Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C, et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 2006;6:12.
-
(2006)
BMC Neurol
, vol.6
, pp. 12
-
-
Yiangou, Y.1
Facer, P.2
Durrenberger, P.3
Chessell, I.P.4
Naylor, A.5
Bountra, C.6
-
252
-
-
34548069374
-
Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: In vitro and in vivo evidence
-
17545311
-
Esposito G, Iuvone T, Savani C, Scuderi C, De Filippis D, Papa M, et al. Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence. J Pharmacol Exp Ther. 2007;322:1144-52.
-
(2007)
J Pharmacol Exp Ther
, vol.322
, pp. 1144-1152
-
-
Esposito, G.1
Iuvone, T.2
Savani, C.3
Scuderi, C.4
De Filippis, D.5
Papa, M.6
-
253
-
-
84890159372
-
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
-
3906668 1:CAS:528:DC%2BC2cXhtFSrt70%3D 24342422
-
Kong W, Li H, Tuma RF, Ganea D. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cell Immunol. 2014;287:1-17.
-
(2014)
Cell Immunol
, vol.287
, pp. 1-17
-
-
Kong, W.1
Li, H.2
Tuma, R.F.3
Ganea, D.4
-
254
-
-
34250717998
-
Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
-
2637559 1:CAS:528:DC%2BD2sXnvFCqsb4%3D 17245417
-
Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab. 2007;27:1387-96.
-
(2007)
J Cereb Blood Flow Metab
, vol.27
, pp. 1387-1396
-
-
Zhang, M.1
Martin, B.R.2
Adler, M.W.3
Razdan, R.K.4
Jallo, J.I.5
Tuma, R.F.6
-
255
-
-
84855812968
-
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice
-
3292807 1:CAS:528:DC%2BC38XksFGnt7k%3D 22248049
-
Martin-Moreno AM, Brera B, Spuch C, Carro E, Garcia-Garcia L, Delgado M, et al. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation. 2012;9:8.
-
(2012)
J Neuroinflammation
, vol.9
, pp. 8
-
-
Martin-Moreno, A.M.1
Brera, B.2
Spuch, C.3
Carro, E.4
Garcia-Garcia, L.5
Delgado, M.6
-
256
-
-
33746261289
-
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
-
16781706
-
Kim K, Moore DH, Makriyannis A, Abood ME. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur J Pharmacol. 2006;542:100-5.
-
(2006)
Eur J Pharmacol
, vol.542
, pp. 100-105
-
-
Kim, K.1
Moore, D.H.2
Makriyannis, A.3
Abood, M.E.4
-
257
-
-
65549125084
-
Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway
-
19357281
-
Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F, Bernardi G, et al. Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci. 2009;29:4564-70.
-
(2009)
J Neurosci
, vol.29
, pp. 4564-4570
-
-
Viscomi, M.T.1
Oddi, S.2
Latini, L.3
Pasquariello, N.4
Florenzano, F.5
Bernardi, G.6
-
258
-
-
77949564177
-
The endocannabinoid system as a target for the treatment of neuronal damage
-
20230193
-
Fernandez-Ruiz J, Garcia C, Sagredo O, Gomez-Ruiz M, de Lago E. The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opin Ther Targets. 2010;14:387-404.
-
(2010)
Expert Opin Ther Targets
, vol.14
, pp. 387-404
-
-
Fernandez-Ruiz, J.1
Garcia, C.2
Sagredo, O.3
Gomez-Ruiz, M.4
De Lago, E.5
-
259
-
-
84964313038
-
Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease
-
24807843
-
Kamat PK, Kalani A, Kyles P, Tyagi SC, Tyagi N. Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease. Cell Biochem Biophys. 2014;70:707-19.
-
(2014)
Cell Biochem Biophys
, vol.70
, pp. 707-719
-
-
Kamat, P.K.1
Kalani, A.2
Kyles, P.3
Tyagi, S.C.4
Tyagi, N.5
-
260
-
-
84555195856
-
Autophagy, mitochondria and oxidative stress: Cross-talk and redox signalling
-
3258656 1:CAS:528:DC%2BC38Xmt1Wksw%3D%3D 22187934
-
Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J. 2012;441:523-40.
-
(2012)
Biochem J
, vol.441
, pp. 523-540
-
-
Lee, J.1
Giordano, S.2
Zhang, J.3
-
261
-
-
84893865299
-
NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice
-
3863573 24379900
-
Hernandes MS, Cafe-Mendes CC, Britto LR. NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice. Oxid Med Cell Longev. 2013;2013:157857.
-
(2013)
Oxid Med Cell Longev
, vol.2013
, pp. 157857
-
-
Hernandes, M.S.1
Cafe-Mendes, C.C.2
Britto, L.R.3
-
262
-
-
84902315628
-
Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor
-
4060213 1:CAS:528:DC%2BC2cXmsVCktro%3D 24944910
-
Hebert-Chatelain E, Reguero L, Puente N, Lutz B, Chaouloff F, Rossignol R, et al. Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor. Molecular Metabolism. 2014;3:495-504.
-
(2014)
Molecular Metabolism
, vol.3
, pp. 495-504
-
-
Hebert-Chatelain, E.1
Reguero, L.2
Puente, N.3
Lutz, B.4
Chaouloff, F.5
Rossignol, R.6
-
263
-
-
79953287136
-
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
-
21356216
-
Yamaori S, Ebisawa J, Okushima Y, Yamamoto I, Watanabe K. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety. Life Sci. 2011;88:730-6.
-
(2011)
Life Sci
, vol.88
, pp. 730-736
-
-
Yamaori, S.1
Ebisawa, J.2
Okushima, Y.3
Yamamoto, I.4
Watanabe, K.5
-
264
-
-
0032493197
-
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants
-
20965 1:CAS:528:DyaK1cXks1SltL0%3D 9653176
-
Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998;95:8268-73.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 8268-8273
-
-
Hampson, A.J.1
Grimaldi, M.2
Axelrod, J.3
Wink, D.4
-
265
-
-
73449084110
-
Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress
-
19441010
-
Comelli F, Bettoni I, Colleoni M, Giagnoni G, Costa B. Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress. Phytother Res. 2009;23:1678-84.
-
(2009)
Phytother Res
, vol.23
, pp. 1678-1684
-
-
Comelli, F.1
Bettoni, I.2
Colleoni, M.3
Giagnoni, G.4
Costa, B.5
-
266
-
-
77955690718
-
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture
-
20561509
-
Cassol-Jr OJ, Comim CM, Silva BR, Hermani FV, Constantino LS, Felisberto F, et al. Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. Brain Res. 2010;1348:128-38.
-
(2010)
Brain Res
, vol.1348
, pp. 128-138
-
-
Cassol, O.J.1
Comim, C.M.2
Silva, B.R.3
Hermani, F.V.4
Constantino, L.S.5
Felisberto, F.6
-
267
-
-
77957845422
-
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure
-
20514518
-
Velez-Pardo C, Jimenez-Del-Rio M, Lores-Arnaiz S, Bustamante J. Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure. Neurochem Res. 2010;35:1323-32.
-
(2010)
Neurochem Res
, vol.35
, pp. 1323-1332
-
-
Velez-Pardo, C.1
Jimenez-Del-Rio, M.2
Lores-Arnaiz, S.3
Bustamante, J.4
-
268
-
-
62449330864
-
Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death
-
2682269 1:CAS:528:DC%2BD1MXislalsrs%3D 19074681
-
Pan H, Mukhopadhyay P, Rajesh M, Patel V, Mukhopadhyay B, Gao B, et al. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther. 2009;328:708-14.
-
(2009)
J Pharmacol Exp Ther
, vol.328
, pp. 708-714
-
-
Pan, H.1
Mukhopadhyay, P.2
Rajesh, M.3
Patel, V.4
Mukhopadhyay, B.5
Gao, B.6
-
269
-
-
33846401540
-
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
-
17196181
-
Garcia-Arencibia M, Gonzalez S, de Lago E, Ramos JA, Mechoulam R, Fernandez-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res. 2007;1134:162-70.
-
(2007)
Brain Res
, vol.1134
, pp. 162-170
-
-
Garcia-Arencibia, M.1
Gonzalez, S.2
De Lago, E.3
Ramos, J.A.4
Mechoulam, R.5
Fernandez-Ruiz, J.6
-
270
-
-
67649881952
-
Cannabinoid system in neurodegeneration: New perspectives in Alzheimer's disease
-
19456285
-
Campillo NE, Paez JA. Cannabinoid system in neurodegeneration: new perspectives in Alzheimer's disease. Mini Rev Med Chem. 2009;9:539-59.
-
(2009)
Mini Rev Med Chem
, vol.9
, pp. 539-559
-
-
Campillo, N.E.1
Paez, J.A.2
-
271
-
-
84876556444
-
Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells
-
3634783 1:CAS:528:DC%2BC3sXntVOisb0%3D 23637839
-
Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Gao F, et al. Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells. PLoS One. 2013;8:e61462.
-
(2013)
PLoS One
, vol.8
, pp. 61462
-
-
Juknat, A.1
Pietr, M.2
Kozela, E.3
Rimmerman, N.4
Levy, R.5
Gao, F.6
-
272
-
-
84856513007
-
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Delta9-tetrahydrocannabinol in BV-2 microglial cells
-
3423229 1:CAS:528:DC%2BC38XltVajtr8%3D 21542829
-
Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Coppola G, et al. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Delta9-tetrahydrocannabinol in BV-2 microglial cells. Br J Pharmacol. 2012;165:2512-28.
-
(2012)
Br J Pharmacol
, vol.165
, pp. 2512-2528
-
-
Juknat, A.1
Pietr, M.2
Kozela, E.3
Rimmerman, N.4
Levy, R.5
Coppola, G.6
-
273
-
-
79960300079
-
Symptom-relieving and neuroprotective effects of the phytocannabinoid Delta(9)-THCV in animal models of Parkinson's disease
-
3165958 1:CAS:528:DC%2BC3MXps1SisrY%3D 21323909
-
Garcia C, Palomo-Garo C, Garcia-Arencibia M, Ramos J, Pertwee R, Fernandez-Ruiz J. Symptom-relieving and neuroprotective effects of the phytocannabinoid Delta(9)-THCV in animal models of Parkinson's disease. Br J Pharmacol. 2011;163:1495-506.
-
(2011)
Br J Pharmacol
, vol.163
, pp. 1495-1506
-
-
Garcia, C.1
Palomo-Garo, C.2
Garcia-Arencibia, M.3
Ramos, J.4
Pertwee, R.5
Fernandez-Ruiz, J.6
-
274
-
-
34547878297
-
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression
-
2189818 1:CAS:528:DC%2BD2sXovFehs7g%3D 17592514
-
Esposito G, Scuderi C, Savani C, Steardo Jr L, De Filippis D, Cottone P, et al. Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol. 2007;151:1272-9.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 1272-1279
-
-
Esposito, G.1
Scuderi, C.2
Savani, C.3
Steardo, Jr.L.4
De Filippis, D.5
Cottone, P.6
-
275
-
-
77953288592
-
Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease
-
20169470
-
Na SJ, DiLella AG, Lis EV, Jones K, Levine DM, Stone DJ, et al. Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease. Neurochem Res. 2010;35:761-72.
-
(2010)
Neurochem Res
, vol.35
, pp. 761-772
-
-
Na, S.J.1
Dilella, A.G.2
Lis, E.V.3
Jones, K.4
Levine, D.M.5
Stone, D.J.6
-
276
-
-
64449087439
-
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
-
19385063
-
Marchalant Y, Brothers HM, Norman GJ, Karelina K, DeVries AC, Wenk GL. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiol Dis. 2009;34:300-7.
-
(2009)
Neurobiol Dis
, vol.34
, pp. 300-307
-
-
Marchalant, Y.1
Brothers, H.M.2
Norman, G.J.3
Karelina, K.4
Devries, A.C.5
Wenk, G.L.6
-
277
-
-
79956293339
-
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer's disease
-
3102548 1:CAS:528:DC%2BC3MXmvFGnurw%3D 21350020
-
Martin-Moreno AM, Reigada D, Ramirez BG, Mechoulam R, Innamorato N, Cuadrado A, et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol Pharmacol. 2011;79:964-73.
-
(2011)
Mol Pharmacol
, vol.79
, pp. 964-973
-
-
Martin-Moreno, A.M.1
Reigada, D.2
Ramirez, B.G.3
Mechoulam, R.4
Innamorato, N.5
Cuadrado, A.6
-
278
-
-
33646078800
-
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement
-
16490313
-
Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, Iuvone T. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett. 2006;399:91-5.
-
(2006)
Neurosci Lett
, vol.399
, pp. 91-95
-
-
Esposito, G.1
De Filippis, D.2
Maiuri, M.C.3
De Stefano, D.4
Carnuccio, R.5
Iuvone, T.6
-
279
-
-
77954175115
-
Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
-
19833407
-
O'Sullivan SE, Kendall DA. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology. 2010;215:611-6.
-
(2010)
Immunobiology
, vol.215
, pp. 611-616
-
-
O'Sullivan, S.E.1
Kendall, D.A.2
-
280
-
-
82655189157
-
Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement
-
3230631 1:CAS:528:DC%2BC3MXhs1Kht73J 22163051
-
Esposito G, Scuderi C, Valenza M, Togna GI, Latina V, De Filippis D, et al. Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PLoS One. 2011;6:e28668.
-
(2011)
PLoS One
, vol.6
, pp. 28668
-
-
Esposito, G.1
Scuderi, C.2
Valenza, M.3
Togna, G.I.4
Latina, V.5
De Filippis, D.6
-
282
-
-
33847657051
-
Immune control by endocannabinoids - New mechanisms of neuroprotection?
-
17196262
-
Ullrich O, Merker K, Timm J, Tauber S. Immune control by endocannabinoids - new mechanisms of neuroprotection? J Neuroimmunol. 2007;184:127-35.
-
(2007)
J Neuroimmunol
, vol.184
, pp. 127-135
-
-
Ullrich, O.1
Merker, K.2
Timm, J.3
Tauber, S.4
-
283
-
-
58049209715
-
Pruning and loss of excitatory synapses by the parkin ubiquitin ligase
-
2614788 1:CAS:528:DC%2BD1cXhsFanurvK 19033459
-
Helton TD, Otsuka T, Lee MC, Mu Y, Ehlers MD. Pruning and loss of excitatory synapses by the parkin ubiquitin ligase. Proc Natl Acad Sci U S A. 2008;105:19492-7.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 19492-19497
-
-
Helton, T.D.1
Otsuka, T.2
Lee, M.C.3
Mu, Y.4
Ehlers, M.D.5
-
284
-
-
0032497504
-
Parkinson's disease. First of two parts
-
9761807
-
Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med. 1998;339:1044-53.
-
(1998)
N Engl J Med
, vol.339
, pp. 1044-1053
-
-
Lang, A.E.1
Lozano, A.M.2
-
285
-
-
0032967382
-
The role of excitotoxicity in neurodegenerative disease: Implications for therapy
-
10334661
-
Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther. 1999;81:163-221.
-
(1999)
Pharmacol Ther
, vol.81
, pp. 163-221
-
-
Doble, A.1
-
286
-
-
4544378328
-
The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B)
-
15380375
-
Juttler E, Potrovita I, Tarabin V, Prinz S, Dong-Si T, Fink G, et al. The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B). Neuropharmacology. 2004;47:580-92.
-
(2004)
Neuropharmacology
, vol.47
, pp. 580-592
-
-
Juttler, E.1
Potrovita, I.2
Tarabin, V.3
Prinz, S.4
Dong-Si, T.5
Fink, G.6
-
287
-
-
84883819557
-
Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate
-
3837442 1:CAS:528:DC%2BC3sXhslyktL%2FN 23600761
-
Sanchez-Blazquez P, Rodriguez-Munoz M, Vicente-Sanchez A, Garzon J. Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. Antioxid Redox Signal. 2013;19:1766-82.
-
(2013)
Antioxid Redox Signal
, vol.19
, pp. 1766-1782
-
-
Sanchez-Blazquez, P.1
Rodriguez-Munoz, M.2
Vicente-Sanchez, A.3
Garzon, J.4
-
288
-
-
65549150497
-
Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategies
-
19367506
-
Janero DR, Vadivel SK, Makriyannis A. Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies. Int Rev Psychiatry. 2009;21:122-33.
-
(2009)
Int Rev Psychiatry
, vol.21
, pp. 122-133
-
-
Janero, D.R.1
Vadivel, S.K.2
Makriyannis, A.3
-
289
-
-
79955849920
-
A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity
-
4124033 1:CAS:528:DC%2BC3MXit1Khsr4%3D 21069475
-
Naidoo V, Nikas SP, Karanian DA, Hwang J, Zhao J, Wood JT, et al. A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity. J Mol Neurosci. 2011;43:493-502.
-
(2011)
J Mol Neurosci
, vol.43
, pp. 493-502
-
-
Naidoo, V.1
Nikas, S.P.2
Karanian, D.A.3
Hwang, J.4
Zhao, J.5
Wood, J.T.6
-
290
-
-
0141865717
-
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
-
14526074
-
Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science. 2003;302:84-8.
-
(2003)
Science
, vol.302
, pp. 84-88
-
-
Marsicano, G.1
Goodenough, S.2
Monory, K.3
Hermann, H.4
Eder, M.5
Cannich, A.6
-
291
-
-
72149122908
-
Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity
-
3951320 1:CAS:528:DC%2BD1MXhsFymsb3O 19654014
-
Zhao P, Leonoudakis D, Abood ME, Beattie EC. Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity. Neuropharmacology. 2010;58:551-8.
-
(2010)
Neuropharmacology
, vol.58
, pp. 551-558
-
-
Zhao, P.1
Leonoudakis, D.2
Abood, M.E.3
Beattie, E.C.4
-
292
-
-
33749512169
-
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum
-
16895732
-
Pintor A, Tebano MT, Martire A, Grieco R, Galluzzo M, Scattoni ML, et al. The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum. Neuropharmacology. 2006;51:1004-12.
-
(2006)
Neuropharmacology
, vol.51
, pp. 1004-1012
-
-
Pintor, A.1
Tebano, M.T.2
Martire, A.3
Grieco, R.4
Galluzzo, M.5
Scattoni, M.L.6
-
294
-
-
0035890082
-
Exogenous anandamide protects rat brain against acute neuronal injury in vivo
-
11698588
-
van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, et al. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci. 2001;21:8765-71.
-
(2001)
J Neurosci
, vol.21
, pp. 8765-8771
-
-
Van Der Stelt, M.1
Veldhuis, W.B.2
Van Haaften, G.W.3
Fezza, F.4
Bisogno, T.5
Bar, P.R.6
-
295
-
-
0035979606
-
Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity
-
11514075
-
Abood ME, Rizvi G, Sallapudi N, McAllister SD. Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci Lett. 2001;309:197-201.
-
(2001)
Neurosci Lett
, vol.309
, pp. 197-201
-
-
Abood, M.E.1
Rizvi, G.2
Sallapudi, N.3
McAllister, S.D.4
-
296
-
-
0031706164
-
Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
-
9730904
-
Shen M, Thayer SA. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol. 1998;54:459-62.
-
(1998)
Mol Pharmacol
, vol.54
, pp. 459-462
-
-
Shen, M.1
Thayer, S.A.2
-
297
-
-
0033561159
-
Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
-
10191316
-
Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci. 1999;19:2987-95.
-
(1999)
J Neurosci
, vol.19
, pp. 2987-2995
-
-
Nagayama, T.1
Sinor, A.D.2
Simon, R.P.3
Chen, J.4
Graham, S.H.5
Jin, K.6
-
298
-
-
0036773310
-
Acute neuronal injury, excitotoxicity, and the endocannabinoid system
-
12428763
-
van der Stelt M, Veldhuis WB, Maccarrone M, Bar PR, Nicolay K, Veldink GA, et al. Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol Neurobiol. 2002;26:317-46.
-
(2002)
Mol Neurobiol
, vol.26
, pp. 317-346
-
-
Van Der Stelt, M.1
Veldhuis, W.B.2
Maccarrone, M.3
Bar, P.R.4
Nicolay, K.5
Veldink, G.A.6
-
299
-
-
84901843938
-
A restricted population of CB1 cannabinoid receptors with neuroprotective activity
-
4050577 1:CAS:528:DC%2BC2cXotlyrsL8%3D 24843137
-
Chiarlone A, Bellocchio L, Blazquez C, Resel E, Soria-Gomez E, Cannich A, et al. A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proc Natl Acad Sci U S A. 2014;111:8257-62.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 8257-8262
-
-
Chiarlone, A.1
Bellocchio, L.2
Blazquez, C.3
Resel, E.4
Soria-Gomez, E.5
Cannich, A.6
-
300
-
-
80053227258
-
CRIP1a switches cannabinoid receptor agonist/antagonist-mediated protection from glutamate excitotoxicity
-
21896317
-
Stauffer B, Wallis KT, Wilson SP, Egertova M, Elphick MR, Lewis DL, et al. CRIP1a switches cannabinoid receptor agonist/antagonist-mediated protection from glutamate excitotoxicity. Neurosci Lett. 2011;503:224-8.
-
(2011)
Neurosci Lett
, vol.503
, pp. 224-228
-
-
Stauffer, B.1
Wallis, K.T.2
Wilson, S.P.3
Egertova, M.4
Elphick, M.R.5
Lewis, D.L.6
-
301
-
-
0027329873
-
Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211
-
8242387
-
Nadler V, Mechoulam R, Sokolovsky M. Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211. Brain Res. 1993;622:79-85.
-
(1993)
Brain Res
, vol.622
, pp. 79-85
-
-
Nadler, V.1
Mechoulam, R.2
Sokolovsky, M.3
-
302
-
-
0028981424
-
45Ca accumulation in rat brain after closed head injury; Attenuation by the novel neuroprotective agent HU-211
-
7583233
-
Nadler V, Biegon A, Beit-Yannai E, Adamchik J, Shohami E. 45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211. Brain Res. 1995;685:1-11.
-
(1995)
Brain Res
, vol.685
, pp. 1-11
-
-
Nadler, V.1
Biegon, A.2
Beit-Yannai, E.3
Adamchik, J.4
Shohami, E.5
-
303
-
-
0029165097
-
Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist
-
7498309
-
Eshhar N, Striem S, Kohen R, Tirosh O, Biegon A. Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist. Eur J Pharmacol. 1995;283:19-29.
-
(1995)
Eur J Pharmacol
, vol.283
, pp. 19-29
-
-
Eshhar, N.1
Striem, S.2
Kohen, R.3
Tirosh, O.4
Biegon, A.5
-
304
-
-
0031914157
-
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission
-
9453561
-
Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, et al. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem. 1998;70:671-6.
-
(1998)
J Neurochem
, vol.70
, pp. 671-676
-
-
Hampson, A.J.1
Bornheim, L.M.2
Scanziani, M.3
Yost, C.S.4
Gray, A.T.5
Hansen, B.M.6
-
305
-
-
0032486361
-
Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease
-
9654336
-
Sanudo-Pena MC, Patrick SL, Khen S, Patrick RL, Tsou K, Walker JM. Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease. Neurosci Lett. 1998;248:171-4.
-
(1998)
Neurosci Lett
, vol.248
, pp. 171-174
-
-
Sanudo-Pena, M.C.1
Patrick, S.L.2
Khen, S.3
Patrick, R.L.4
Tsou, K.5
Walker, J.M.6
-
306
-
-
0034287012
-
Functional changes of the basal ganglia circuitry in Parkinson's disease
-
10821982
-
Blandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000;62:63-88.
-
(2000)
Prog Neurobiol
, vol.62
, pp. 63-88
-
-
Blandini, F.1
Nappi, G.2
Tassorelli, C.3
Martignoni, E.4
-
308
-
-
84895759461
-
The influence of cannabinoids on generic traits of neurodegeneration
-
3954477 1:CAS:528:DC%2BC2cXjsVens70%3D 24172185
-
Fagan SG, Campbell VA. The influence of cannabinoids on generic traits of neurodegeneration. Br J Pharmacol. 2014;171:1347-60.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 1347-1360
-
-
Fagan, S.G.1
Campbell, V.A.2
-
309
-
-
84862994947
-
The role of bioactive compounds on the promotion of neurite outgrowth
-
22664464
-
More SV, Koppula S, Kim IS, Kumar H, Kim BW, Choi DK. The role of bioactive compounds on the promotion of neurite outgrowth. Molecules. 2012;17:6728-53.
-
(2012)
Molecules
, vol.17
, pp. 6728-6753
-
-
More, S.V.1
Koppula, S.2
Kim, I.S.3
Kumar, H.4
Kim, B.W.5
Choi, D.K.6
-
310
-
-
84917682984
-
Programming of neural cells by (endo)cannabinoids: From physiological rules to emerging therapies
-
25409697
-
Maccarrone M, Guzman M, Mackie K, Doherty P, Harkany T. Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci. 2014;15:786-801.
-
(2014)
Nat Rev Neurosci
, vol.15
, pp. 786-801
-
-
Maccarrone, M.1
Guzman, M.2
Mackie, K.3
Doherty, P.4
Harkany, T.5
-
311
-
-
3342979420
-
Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice
-
15266010
-
Jin K, Xie L, Kim SH, Parmentier-Batteur S, Sun Y, Mao XO, et al. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol. 2004;66:204-8.
-
(2004)
Mol Pharmacol
, vol.66
, pp. 204-208
-
-
Jin, K.1
Xie, L.2
Kim, S.H.3
Parmentier-Batteur, S.4
Sun, Y.5
Mao, X.O.6
-
312
-
-
34548241342
-
The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis
-
17556369
-
Aguado T, Romero E, Monory K, Palazuelos J, Sendtner M, Marsicano G, et al. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem. 2007;282:23892-8.
-
(2007)
J Biol Chem
, vol.282
, pp. 23892-23898
-
-
Aguado, T.1
Romero, E.2
Monory, K.3
Palazuelos, J.4
Sendtner, M.5
Marsicano, G.6
-
313
-
-
33847043132
-
CB2 cannabinoid receptors promote mouse neural stem cell proliferation
-
17328768
-
Molina-Holgado F, Rubio-Araiz A, Garcia-Ovejero D, Williams RJ, Moore JD, Arevalo-Martin A, et al. CB2 cannabinoid receptors promote mouse neural stem cell proliferation. Eur J Neurosci. 2007;25:629-34.
-
(2007)
Eur J Neurosci
, vol.25
, pp. 629-634
-
-
Molina-Holgado, F.1
Rubio-Araiz, A.2
Garcia-Ovejero, D.3
Williams, R.J.4
Moore, J.D.5
Arevalo-Martin, A.6
-
314
-
-
84887973589
-
Neuroimmmune interactions of cannabinoids in neurogenesis: Focus on interleukin-1beta (IL-1beta) signalling
-
24256257
-
Garcia-Ovejero D, Arevalo-Martin A, Navarro-Galve B, Pinteaux E, Molina-Holgado E, Molina-Holgado F. Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1beta (IL-1beta) signalling. Biochem Soc Trans. 2013;41:1577-82.
-
(2013)
Biochem Soc Trans
, vol.41
, pp. 1577-1582
-
-
Garcia-Ovejero, D.1
Arevalo-Martin, A.2
Navarro-Galve, B.3
Pinteaux, E.4
Molina-Holgado, E.5
Molina-Holgado, F.6
-
315
-
-
84868129085
-
Endocannabinoids in nervous system health and disease: The big picture in a nutshell
-
3481537 1:CAS:528:DC%2BC38XhvVKgtLzI 23108539
-
Skaper SD, Di Marzo V. Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philos Trans R Soc Lond B Biol Sci. 2012;367:3193-200.
-
(2012)
Philos Trans R Soc Lond B Biol Sci
, vol.367
, pp. 3193-3200
-
-
Skaper, S.D.1
Di Marzo, V.2
-
317
-
-
84925497477
-
Neural stem cells in Parkinson's disease: A role for neurogenesis defects in onset and progression
-
25403878
-
Le Grand JN, Gonzalez-Cano L, Pavlou MA, Schwamborn JC. Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression. Cell Mol Life Sci. 2015;72:773-97.
-
(2015)
Cell Mol Life Sci
, vol.72
, pp. 773-797
-
-
Le Grand, J.N.1
Gonzalez-Cano, L.2
Pavlou, M.A.3
Schwamborn, J.C.4
-
318
-
-
79952584387
-
Mutant alpha-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
-
3583292 1:CAS:528:DC%2BC3MXksFOrurs%3D 21108729
-
Peng J, Andersen JK. Mutant alpha-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Aging Cell. 2011;10:255-62.
-
(2011)
Aging Cell
, vol.10
, pp. 255-262
-
-
Peng, J.1
Andersen, J.K.2
-
319
-
-
84866405384
-
Alpha-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1
-
3442504 1:CAS:528:DC%2BC38XhtlGgsbfN 22833673
-
Desplats P, Spencer B, Crews L, Pathel P, Morvinski-Friedmann D, Kosberg K, et al. alpha-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1. J Biol Chem. 2012;287:31691-702.
-
(2012)
J Biol Chem
, vol.287
, pp. 31691-31702
-
-
Desplats, P.1
Spencer, B.2
Crews, L.3
Pathel, P.4
Morvinski-Friedmann, D.5
Kosberg, K.6
-
320
-
-
84881113966
-
Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice
-
4324756 1:CAS:528:DC%2BC3sXhsVyltbjP 23867236
-
Marxreiter F, Ettle B, May VE, Esmer H, Patrick C, Kragh CL, et al. Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice. Neurobiol Dis. 2013;59:38-51.
-
(2013)
Neurobiol Dis
, vol.59
, pp. 38-51
-
-
Marxreiter, F.1
Ettle, B.2
May, V.E.3
Esmer, H.4
Patrick, C.5
Kragh, C.L.6
-
321
-
-
1842633560
-
Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity
-
15078543
-
Khaspekov LG, Brenz Verca MS, Frumkina LE, Hermann H, Marsicano G, Lutz B. Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. Eur J Neurosci. 2004;19:1691-8.
-
(2004)
Eur J Neurosci
, vol.19
, pp. 1691-1698
-
-
Khaspekov, L.G.1
Brenz Verca, M.S.2
Frumkina, L.E.3
Hermann, H.4
Marsicano, G.5
Lutz, B.6
-
322
-
-
14844310369
-
Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats
-
15755552
-
Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, Croll S. Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol. 2005;192:348-56.
-
(2005)
Exp Neurol
, vol.192
, pp. 348-356
-
-
Scharfman, H.1
Goodman, J.2
Macleod, A.3
Phani, S.4
Antonelli, C.5
Croll, S.6
-
323
-
-
84884277445
-
Serum brain-derived neurotrophic factor levels in different neurological diseases
-
3760208 24024214
-
Ventriglia M, Zanardini R, Bonomini C, Zanetti O, Volpe D, Pasqualetti P, et al. Serum brain-derived neurotrophic factor levels in different neurological diseases. Biomed Res Int. 2013;2013:901082.
-
(2013)
Biomed Res Int
, vol.2013
, pp. 901082
-
-
Ventriglia, M.1
Zanardini, R.2
Bonomini, C.3
Zanetti, O.4
Volpe, D.5
Pasqualetti, P.6
-
324
-
-
77951255298
-
Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease
-
19847468
-
Scalzo P, Kummer A, Bretas TL, Cardoso F, Teixeira AL. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. J Neurol. 2010;257:540-5.
-
(2010)
J Neurol
, vol.257
, pp. 540-545
-
-
Scalzo, P.1
Kummer, A.2
Bretas, T.L.3
Cardoso, F.4
Teixeira, A.L.5
-
325
-
-
70350570450
-
BDNF regulates neuronal sensitivity to endocannabinoids
-
19818836
-
Maison P, Walker DJ, Walsh FS, Williams G, Doherty P. BDNF regulates neuronal sensitivity to endocannabinoids. Neurosci Lett. 2009;467:90-4.
-
(2009)
Neurosci Lett
, vol.467
, pp. 90-94
-
-
Maison, P.1
Walker, D.J.2
Walsh, F.S.3
Williams, G.4
Doherty, P.5
-
326
-
-
33749013040
-
Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis
-
16831955
-
Kim SH, Won SJ, Mao XO, Ledent C, Jin K, Greenberg DA. Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis. J Pharmacol Exp Ther. 2006;319:150-4.
-
(2006)
J Pharmacol Exp Ther
, vol.319
, pp. 150-154
-
-
Kim, S.H.1
Won, S.J.2
Mao, X.O.3
Ledent, C.4
Jin, K.5
Greenberg, D.A.6
-
327
-
-
47749088572
-
A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner
-
18562209
-
Goncalves MB, Suetterlin P, Yip P, Molina-Holgado F, Walker DJ, Oudin MJ, et al. A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol Cell Neurosci. 2008;38:526-36.
-
(2008)
Mol Cell Neurosci
, vol.38
, pp. 526-536
-
-
Goncalves, M.B.1
Suetterlin, P.2
Yip, P.3
Molina-Holgado, F.4
Walker, D.J.5
Oudin, M.J.6
-
328
-
-
79952536002
-
The multiplicity of action of cannabinoids: Implications for treating neurodegeneration
-
20875047
-
Gowran A, Noonan J, Campbell VA. The multiplicity of action of cannabinoids: implications for treating neurodegeneration. CNS Neurosci Ther. 2011;17:637-44.
-
(2011)
CNS Neurosci Ther
, vol.17
, pp. 637-644
-
-
Gowran, A.1
Noonan, J.2
Campbell, V.A.3
-
329
-
-
84855496796
-
CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling
-
3256884 1:CAS:528:DC%2BC38XjslymsA%3D%3D 22102284
-
Palazuelos J, Ortega Z, Diaz-Alonso J, Guzman M, Galve-Roperh I. CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling. J Biol Chem. 2012;287:1198-209.
-
(2012)
J Biol Chem
, vol.287
, pp. 1198-1209
-
-
Palazuelos, J.1
Ortega, Z.2
Diaz-Alonso, J.3
Guzman, M.4
Galve-Roperh, I.5
-
330
-
-
84872800314
-
Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells
-
3553153 1:CAS:528:DC%2BC3sXitVymtbg%3D 23372698
-
Compagnucci C, Di Siena S, Bustamante MB, Di Giacomo D, Di Tommaso M, Maccarrone M, et al. Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells. PLoS One. 2013;8:e54271.
-
(2013)
PLoS One
, vol.8
, pp. 54271
-
-
Compagnucci, C.1
Di Siena, S.2
Bustamante, M.B.3
Di Giacomo, D.4
Di Tommaso, M.5
Maccarrone, M.6
-
331
-
-
84891277457
-
The cannabinoid CB(2) receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis
-
3904265 1:CAS:528:DC%2BC3sXhvFOntrzF 24148086
-
Avraham HK, Jiang S, Fu Y, Rockenstein E, Makriyannis A, Zvonok A, et al. The cannabinoid CB(2) receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis. Br J Pharmacol. 2014;171:468-79.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 468-479
-
-
Avraham, H.K.1
Jiang, S.2
Fu, Y.3
Rockenstein, E.4
Makriyannis, A.5
Zvonok, A.6
-
332
-
-
79959920826
-
Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease
-
21699489
-
Little JP, Villanueva EB, Klegeris A. Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease. Mini Rev Med Chem. 2011;11:582-90.
-
(2011)
Mini Rev Med Chem
, vol.11
, pp. 582-590
-
-
Little, J.P.1
Villanueva, E.B.2
Klegeris, A.3
-
333
-
-
77949489748
-
In vivo pharmacology of endocannabinoids and their metabolic inhibitors: Therapeutic implications in Parkinson's disease and abuse liability
-
2844932 1:CAS:528:DC%2BC3cXjslShsrc%3D 19523530
-
Giuffrida A, McMahon LR. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Prostaglandins Other Lipid Mediat. 2010;91:90-103.
-
(2010)
Prostaglandins Other Lipid Mediat
, vol.91
, pp. 90-103
-
-
Giuffrida, A.1
McMahon, L.R.2
-
334
-
-
84902171176
-
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
-
24778283
-
Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82:1556-63.
-
(2014)
Neurology
, vol.82
, pp. 1556-1563
-
-
Koppel, B.S.1
Brust, J.C.2
Fife, T.3
Bronstein, J.4
Youssof, S.5
Gronseth, G.6
-
335
-
-
84897024046
-
Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: An open-label observational study
-
24614667
-
Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37:41-4.
-
(2014)
Clin Neuropharmacol
, vol.37
, pp. 41-44
-
-
Lotan, I.1
Treves, T.A.2
Roditi, Y.3
Djaldetti, R.4
-
336
-
-
84908519197
-
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
-
4226453 1:CAS:528:DC%2BC2cXitFOks7%2FI 25395834
-
Song L, Yang X, Ma Y, Wu N, Liu Z. The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats. Drug Des Devel Ther. 2014;8:2173-9.
-
(2014)
Drug des Devel Ther
, vol.8
, pp. 2173-2179
-
-
Song, L.1
Yang, X.2
Ma, Y.3
Wu, N.4
Liu, Z.5
-
337
-
-
84939166879
-
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by Lps in Rats
-
Epub ahead of print
-
Sayd A, Anton M, Alen F, Caso J, Pavon J, Leza J et al. Systemic Administration Of Oleoylethanolamide Protects From Neuroinflammation And Anhedonia Induced By Lps In Rats. Int J Neuropsychopharmacol. 2014. 1457-1461. Epub ahead of print.
-
(2014)
Int J Neuropsychopharmacol
, pp. 1457-1461
-
-
Sayd, A.1
Anton, M.2
Alen, F.3
Caso, J.4
Pavon, J.5
Leza, J.6
-
338
-
-
84859924311
-
Cannabinoids prevent lipopolysaccharide-induced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase
-
22436849
-
Chung ES, Bok E, Chung YC, Baik HH, Jin BK. Cannabinoids prevent lipopolysaccharide-induced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase. Brain Res. 2012;1451:110-6.
-
(2012)
Brain Res
, vol.1451
, pp. 110-116
-
-
Chung, E.S.1
Bok, E.2
Chung, Y.C.3
Baik, H.H.4
Jin, B.K.5
-
339
-
-
84866451855
-
Delta(9)-tetrahydrocannabinol (Delta(9)-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease
-
22236282
-
Carroll CB, Zeissler ML, Hanemann CO, Zajicek JP. Delta(9)-tetrahydrocannabinol (Delta(9)-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. Neuropathol Appl Neurobiol. 2012;38:535-47.
-
(2012)
Neuropathol Appl Neurobiol
, vol.38
, pp. 535-547
-
-
Carroll, C.B.1
Zeissler, M.L.2
Hanemann, C.O.3
Zajicek, J.P.4
-
340
-
-
84861812571
-
Effects of cannabinoids Delta(9)-tetrahydrocannabinol, Delta(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures
-
22571976
-
Moldzio R, Pacher T, Krewenka C, Kranner B, Novak J, Duvigneau JC, et al. Effects of cannabinoids Delta(9)-tetrahydrocannabinol, Delta(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures. Phytomedicine. 2012;19:819-24.
-
(2012)
Phytomedicine
, vol.19
, pp. 819-824
-
-
Moldzio, R.1
Pacher, T.2
Krewenka, C.3
Kranner, B.4
Novak, J.5
Duvigneau, J.C.6
-
341
-
-
84856516709
-
The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats
-
22192465
-
Martinez A, Macheda T, Morgese MG, Trabace L, Giuffrida A. The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. Neurosci Res. 2012;72:236-42.
-
(2012)
Neurosci Res
, vol.72
, pp. 236-242
-
-
Martinez, A.1
Macheda, T.2
Morgese, M.G.3
Trabace, L.4
Giuffrida, A.5
-
342
-
-
84866183326
-
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction
-
3145842 21829757
-
Jeon P, Yang S, Jeong H, Kim H. Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction. Anat Cell Biol. 2011;44:135-42.
-
(2011)
Anat Cell Biol
, vol.44
, pp. 135-142
-
-
Jeon, P.1
Yang, S.2
Jeong, H.3
Kim, H.4
-
343
-
-
83755178512
-
Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation
-
22079984
-
Chung YC, Bok E, Huh SH, Park JY, Yoon SH, Kim SR, et al. Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation. J Immunol. 2011;187:6508-17.
-
(2011)
J Immunol
, vol.187
, pp. 6508-6517
-
-
Chung, Y.C.1
Bok, E.2
Huh, S.H.3
Park, J.Y.4
Yoon, S.H.5
Kim, S.R.6
-
344
-
-
78149471067
-
The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats
-
20888328
-
Walsh S, Gorman AM, Finn DP, Dowd E. The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats. Brain Res. 2010;1363:40-8.
-
(2010)
Brain Res
, vol.1363
, pp. 40-48
-
-
Walsh, S.1
Gorman, A.M.2
Finn, D.P.3
Dowd, E.4
-
345
-
-
67649644733
-
The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease
-
19414037
-
Kelsey JE, Harris O, Cassin J. The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease. Behav Brain Res. 2009;203:304-7.
-
(2009)
Behav Brain Res
, vol.203
, pp. 304-307
-
-
Kelsey, J.E.1
Harris, O.2
Cassin, J.3
-
346
-
-
84941177275
-
The CB cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
-
Epub ahead of print
-
Blazquez C, Chiarlone A, Bellocchio L, Resel E, Pruunsild P, Garcia-Rincon D et al. The CB cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway. Cell Death Differ. 2015. Epub ahead of print.
-
(2015)
Cell Death Differ
-
-
Blazquez, C.1
Chiarlone, A.2
Bellocchio, L.3
Resel, E.4
Pruunsild, P.5
Garcia-Rincon, D.6
-
347
-
-
34547984234
-
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors
-
17672854
-
Sagredo O, Ramos JA, Decio A, Mechoulam R, Fernandez-Ruiz J. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Eur J Neurosci. 2007;26:843-51.
-
(2007)
Eur J Neurosci
, vol.26
, pp. 843-851
-
-
Sagredo, O.1
Ramos, J.A.2
Decio, A.3
Mechoulam, R.4
Fernandez-Ruiz, J.5
-
348
-
-
84878863032
-
CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AbetaPP/PS1 mice
-
23515018
-
Aso E, Juves S, Maldonado R, Ferrer I. CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AbetaPP/PS1 mice. J Alzheimers Dis. 2013;35:847-58.
-
(2013)
J Alzheimers Dis
, vol.35
, pp. 847-858
-
-
Aso, E.1
Juves, S.2
Maldonado, R.3
Ferrer, I.4
-
349
-
-
84880208269
-
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy
-
23478312
-
Casarejos MJ, Perucho J, Gomez A, Munoz MP, Fernandez-Estevez M, Sagredo O, et al. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. J Alzheimers Dis. 2013;35:525-39.
-
(2013)
J Alzheimers Dis
, vol.35
, pp. 525-539
-
-
Casarejos, M.J.1
Perucho, J.2
Gomez, A.3
Munoz, M.P.4
Fernandez-Estevez, M.5
Sagredo, O.6
-
350
-
-
84870489074
-
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
-
22795792
-
Wu J, Bie B, Yang H, Xu JJ, Brown DL, Naguib M. Activation of the CB2 receptor system reverses amyloid-induced memory deficiency. Neurobiol Aging. 2013;34:791-804.
-
(2013)
Neurobiol Aging.
, vol.34
, pp. 791-804
-
-
Wu, J.1
Bie, B.2
Yang, H.3
Xu, J.J.4
Brown, D.L.5
Naguib, M.6
-
351
-
-
84928044075
-
Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
-
25252936
-
Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Munoz E, Sagredo O. Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice. Neurotherapeutics. 2015;12:185-99.
-
(2015)
Neurotherapeutics
, vol.12
, pp. 185-199
-
-
Valdeolivas, S.1
Navarrete, C.2
Cantarero, I.3
Bellido, M.L.4
Munoz, E.5
Sagredo, O.6
-
352
-
-
77952661567
-
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease
-
2931573 1:CAS:528:DC%2BC3cXpslyqsrk%3D 20590577
-
Scotter EL, Goodfellow CE, Graham ES, Dragunow M, Glass M. Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease. Br J Pharmacol. 2010;160:747-61.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 747-761
-
-
Scotter, E.L.1
Goodfellow, C.E.2
Graham, E.S.3
Dragunow, M.4
Glass, M.5
|